{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re\n",
    "import nltk\n",
    "import csv\n",
    "from IPython.display import Image\n",
    "from IPython.display import display"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/chiachienhung/anaconda/lib/python3.6/site-packages/IPython/core/interactiveshell.py:2717: DtypeWarning: Columns (3,4,5,6,9,10,11,12,14,16,17) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  interactivity=interactivity, compiler=compiler, result=result)\n"
     ]
    }
   ],
   "source": [
    "import chardet\n",
    "import pandas as pd\n",
    "\n",
    "with open('Final_TW_1404.csv', 'rb') as f:\n",
    "    result = chardet.detect(f.read())  # or readline if the file is large\n",
    "    #print(result)\n",
    "disease = pd.read_csv('Final_TW_1404.csv',encoding=result['encoding'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Created.At</th>\n",
       "      <th>From.User</th>\n",
       "      <th>From.User.Id</th>\n",
       "      <th>To.User</th>\n",
       "      <th>To.User.Id</th>\n",
       "      <th>Language</th>\n",
       "      <th>Source</th>\n",
       "      <th>Text</th>\n",
       "      <th>Geo.Location.Latitude</th>\n",
       "      <th>Geo.Location.Longitude</th>\n",
       "      <th>Retweet.Count</th>\n",
       "      <th>Id</th>\n",
       "      <th>key</th>\n",
       "      <th>favorited</th>\n",
       "      <th>favoriteCount</th>\n",
       "      <th>isRetweet</th>\n",
       "      <th>retweeted</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>3/23/2017 21:09</td>\n",
       "      <td>Julianne Hough</td>\n",
       "      <td>16579345</td>\n",
       "      <td>NaN</td>\n",
       "      <td>-1</td>\n",
       "      <td>en</td>\n",
       "      <td>&lt;a href='http://instagram.com' rel='nofollow'&gt;...</td>\n",
       "      <td>IĄŻm so excited to partner with AbbVie on a ca...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>34</td>\n",
       "      <td>8.45E+17</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>3/25/2017 21:25</td>\n",
       "      <td>K D Hill</td>\n",
       "      <td>8.13E+17</td>\n",
       "      <td>NaN</td>\n",
       "      <td>-1</td>\n",
       "      <td>en</td>\n",
       "      <td>&lt;a href='http://twitter.com/download/iphone' r...</td>\n",
       "      <td>RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>24</td>\n",
       "      <td>8.46E+17</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>3/25/2017 20:12</td>\n",
       "      <td>Heather</td>\n",
       "      <td>2429350242</td>\n",
       "      <td>NaN</td>\n",
       "      <td>-1</td>\n",
       "      <td>en</td>\n",
       "      <td>&lt;a href='http://www.facebook.com/twitter' rel=...</td>\n",
       "      <td>Empowering Women to Speak Up About Endometrios...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>8.46E+17</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0       Created.At       From.User From.User.Id To.User  \\\n",
       "0           1  3/23/2017 21:09  Julianne Hough     16579345     NaN   \n",
       "1           2  3/25/2017 21:25        K D Hill     8.13E+17     NaN   \n",
       "2           3  3/25/2017 20:12         Heather   2429350242     NaN   \n",
       "\n",
       "  To.User.Id Language                                             Source  \\\n",
       "0         -1       en  <a href='http://instagram.com' rel='nofollow'>...   \n",
       "1         -1       en  <a href='http://twitter.com/download/iphone' r...   \n",
       "2         -1       en  <a href='http://www.facebook.com/twitter' rel=...   \n",
       "\n",
       "                                                Text Geo.Location.Latitude  \\\n",
       "0  IĄŻm so excited to partner with AbbVie on a ca...                   NaN   \n",
       "1  RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...                   NaN   \n",
       "2  Empowering Women to Speak Up About Endometrios...                   NaN   \n",
       "\n",
       "  Geo.Location.Longitude Retweet.Count        Id     key favorited  \\\n",
       "0                    NaN            34  8.45E+17  abbvie       NaN   \n",
       "1                    NaN            24  8.46E+17  abbvie       NaN   \n",
       "2                    NaN             0  8.46E+17  abbvie       NaN   \n",
       "\n",
       "   favoriteCount isRetweet retweeted  \n",
       "0            NaN       NaN       NaN  \n",
       "1            NaN       NaN       NaN  \n",
       "2            NaN       NaN       NaN  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#59333\n",
    "display(disease.head(3))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>language</th>\n",
       "      <th>message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/23/2017 21:09</td>\n",
       "      <td>en</td>\n",
       "      <td>IĄŻm so excited to partner with AbbVie on a ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/25/2017 21:25</td>\n",
       "      <td>en</td>\n",
       "      <td>RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/25/2017 20:12</td>\n",
       "      <td>en</td>\n",
       "      <td>Empowering Women to Speak Up About Endometrios...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      key     created_time language  \\\n",
       "0  abbvie  3/23/2017 21:09       en   \n",
       "1  abbvie  3/25/2017 21:25       en   \n",
       "2  abbvie  3/25/2017 20:12       en   \n",
       "\n",
       "                                             message  \n",
       "0  IĄŻm so excited to partner with AbbVie on a ca...  \n",
       "1  RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...  \n",
       "2  Empowering Women to Speak Up About Endometrios...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "59333 38752\n"
     ]
    }
   ],
   "source": [
    "#disease = pd.read_csv('Final_utf16LE.csv', encoding='ISO-8859-2')\n",
    "#display(disease.head(5))\n",
    "df = pd.DataFrame(disease, columns = ['key','Created.At','Language', 'Text'])\n",
    "rm_duplicates = df.drop_duplicates(subset=['key','Text'])\n",
    "#rm_duplicates_y = df.drop_duplicates(subset=['key','message.y'])\n",
    "\n",
    "#display(rm_duplicates_x.head(10))\n",
    "#display(rm_duplicates_y.head(10))\n",
    "message=rm_duplicates[['key','Created.At','Language', 'Text']]\n",
    "#message_y=rm_duplicates_y[['key', 'id.x', 'created_time.y', 'message.y']]\n",
    "message.columns=['key', 'created_time', 'language','message']\n",
    "#message_y.columns=['key', 'id.x', 'created_time','message']\n",
    "display(message.head(3))\n",
    "#display(message_y.head(10))\n",
    "print(len(df),len(message))\n",
    "#frames = [message_x, message_y]\n",
    "#result = pd.concat(frames, keys=['message.x', 'message.y'])\n",
    "#display(result.head(10))\n",
    "#print(len(result))\n",
    "message.to_csv(\"twitter_utf16.csv\", encoding='UTF-16LE',columns = ['key', 'created_time', 'language','message'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>language</th>\n",
       "      <th>message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/23/2017 21:09</td>\n",
       "      <td>en</td>\n",
       "      <td>IĄŻm so excited to partner with AbbVie on a ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/25/2017 21:25</td>\n",
       "      <td>en</td>\n",
       "      <td>RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>abbvie</td>\n",
       "      <td>3/25/2017 20:12</td>\n",
       "      <td>en</td>\n",
       "      <td>Empowering Women to Speak Up About Endometrios...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0     key     created_time language  \\\n",
       "0           0  abbvie  3/23/2017 21:09       en   \n",
       "1           1  abbvie  3/25/2017 21:25       en   \n",
       "2           2  abbvie  3/25/2017 20:12       en   \n",
       "\n",
       "                                             message  \n",
       "0  IĄŻm so excited to partner with AbbVie on a ca...  \n",
       "1  RT @MichaelJFoxOrg: MJFF and AbbVie partnered ...  \n",
       "2  Empowering Women to Speak Up About Endometrios...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "38752"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "post_comment = pd.read_csv('twitter_utf16.csv', encoding='UTF-16LE') \n",
    "#df.apply(lambda x: pd.lib.infer_dtype(x.values))\n",
    "#post_comment.columns=['xy','docid','key', 'id.x', 'created_time','message']\n",
    "display(post_comment.head(3))\n",
    "display(len(post_comment['key']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/chiachienhung/anaconda/lib/python3.6/site-packages/ipykernel/__main__.py:2: FutureWarning: sort(columns=....) is deprecated, use sort_values(by=.....)\n",
      "  from ipykernel import kernelapp as app\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>language</th>\n",
       "      <th>message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>5441</th>\n",
       "      <td>6540</td>\n",
       "      <td>ibrutinib</td>\n",
       "      <td>1/17/2003 0:03</td>\n",
       "      <td>en</td>\n",
       "      <td>#Leukemia BTK PLCG2 Mutations Presage CLL Rela...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4143</th>\n",
       "      <td>4988</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4144</th>\n",
       "      <td>4989</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0         key    created_time language  \\\n",
       "5441        6540   ibrutinib  1/17/2003 0:03       en   \n",
       "4143        4988  adalimumab  1/17/2003 0:04       en   \n",
       "4144        4989  adalimumab  1/17/2003 0:04       en   \n",
       "\n",
       "                                                message  \n",
       "5441  #Leukemia BTK PLCG2 Mutations Presage CLL Rela...  \n",
       "4143  Adalimumab Effective for Uveitis Associated wi...  \n",
       "4144  Adalimumab Effective for Uveitis Associated wi...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "rm_na = post_comment.dropna()\n",
    "dtime = rm_na.sort(['created_time'])\n",
    "dtime = dtime[0:9434]\n",
    "display(dtime.head(3))\n",
    "dfinal = pd.DataFrame(dtime, columns = ['key', 'created_time', 'language','message'])\n",
    "dfinal.to_csv(\"twitter_rm_utf16.csv\", encoding='UTF-16LE',columns = ['key', 'created_time', 'language','message'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>language</th>\n",
       "      <th>message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>5441</td>\n",
       "      <td>ibrutinib</td>\n",
       "      <td>1/17/2003 0:03</td>\n",
       "      <td>en</td>\n",
       "      <td>#Leukemia BTK PLCG2 Mutations Presage CLL Rela...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4143</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4144</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0         key    created_time language  \\\n",
       "0        5441   ibrutinib  1/17/2003 0:03       en   \n",
       "1        4143  adalimumab  1/17/2003 0:04       en   \n",
       "2        4144  adalimumab  1/17/2003 0:04       en   \n",
       "\n",
       "                                             message  \n",
       "0  #Leukemia BTK PLCG2 Mutations Presage CLL Rela...  \n",
       "1  Adalimumab Effective for Uveitis Associated wi...  \n",
       "2  Adalimumab Effective for Uveitis Associated wi...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9434\n"
     ]
    }
   ],
   "source": [
    "dstart = pd.read_csv('twitter_rm_utf16.csv', encoding='UTF-16LE')\n",
    "display(dstart.head(3))\n",
    "print(len(dstart['key']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from nltk import wordpunct_tokenize\n",
    "from nltk.corpus import stopwords\n",
    "def _calculate_languages_ratios(text):\n",
    "    languages_ratios = {}\n",
    "    tokens = wordpunct_tokenize(text)\n",
    "    words = [word.lower() for word in tokens]\n",
    "    for language in stopwords.fileids():\n",
    "        stopwords_set = set(stopwords.words(language))\n",
    "        words_set = set(words)\n",
    "        common_elements = words_set.intersection(stopwords_set)\n",
    "\n",
    "        languages_ratios[language] = len(common_elements) # language \"score\"\n",
    "\n",
    "    return languages_ratios\n",
    "def detect_language(text):\n",
    "    ratios = _calculate_languages_ratios(text)\n",
    "    most_rated_language = max(ratios, key=ratios.get)\n",
    "    return most_rated_language"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package stopwords to\n",
      "[nltk_data]     /Users/chiachienhung/nltk_data...\n",
      "[nltk_data]   Package stopwords is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import re\n",
    "import nltk\n",
    "import csv\n",
    "nltk.download('stopwords')\n",
    "from nltk.corpus import stopwords\n",
    "#pip install langdetect\n",
    "from langdetect import detect\n",
    "\n",
    "df_twitter = pd.read_csv('twitter_rm_utf16.csv', encoding = 'utf-16LE', sep=',')\n",
    "                         \n",
    "with open('twitter_preprocessing_utf16.csv', 'w', encoding='UTF-16LE', newline='') as csvfile:\n",
    "    column = [['no','key', 'created_time', 'language','message','lang','re_message']]\n",
    "    writer = csv.writer(csvfile)\n",
    "    writer.writerows(column)\n",
    "    \n",
    "for i in range(len(df_twitter['message'])):    \n",
    "    features = []\n",
    "    features.append(i)\n",
    "    features.append(df_twitter['key'][i])\n",
    "    features.append(df_twitter['created_time'][i])\n",
    "    features.append(df_twitter['language'][i])\n",
    "    features.append(df_twitter['message'][i])\n",
    "    if(str(df_twitter['message'][i])==\"nan\"):\n",
    "        features.append('english')\n",
    "        features.append(df_twitter['message'][i])\n",
    "    else:\n",
    "        #tokens = nltk.word_tokenize(str(df_twitter['message'][i]))\n",
    "        tokens=' '.join(re.findall(r\"[\\w']+\", str(df_twitter['message'][i]))).lower().split()\n",
    "        postag=nltk.pos_tag(tokens)\n",
    "        irlist=[',','.',':','#',';','CD','WRB','RB','PRP','...',')','(','-','``','@']\n",
    "        wordlist=['co', 'https', 'http','rt']\n",
    "        adjandn = [word for word,pos in postag if pos not in irlist and word not in wordlist and len(word)>2]\n",
    "        #adjandn = [word for word,pos in postag if pos not in irlist]\n",
    "        lang=detect_language(df_twitter['message'][i])\n",
    "        features.append(lang)\n",
    "        #print(i,lang)\n",
    "        stop = set(stopwords.words(lang))\n",
    "        wordlist = [i for i in adjandn if i not in stop]\n",
    "        features.append(' '.join(wordlist))\n",
    "    with open('twitter_preprocessing_utf16.csv', 'a', encoding='UTF-16LE', newline='') as csvfile:\n",
    "        writer = csv.writer(csvfile)\n",
    "        writer.writerows([features])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>no</th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>language</th>\n",
       "      <th>message</th>\n",
       "      <th>lang</th>\n",
       "      <th>re_message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>ibrutinib</td>\n",
       "      <td>1/17/2003 0:03</td>\n",
       "      <td>en</td>\n",
       "      <td>#Leukemia BTK PLCG2 Mutations Presage CLL Rela...</td>\n",
       "      <td>english</td>\n",
       "      <td>leukemia btk plcg2 mutations presage cll relap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "      <td>english</td>\n",
       "      <td>effective uveitis associated juvenile idiopath...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>en</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "      <td>english</td>\n",
       "      <td>effective uveitis associated juvenile idiopath...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   no         key    created_time language  \\\n",
       "0   0   ibrutinib  1/17/2003 0:03       en   \n",
       "1   1  adalimumab  1/17/2003 0:04       en   \n",
       "2   2  adalimumab  1/17/2003 0:04       en   \n",
       "\n",
       "                                             message     lang  \\\n",
       "0  #Leukemia BTK PLCG2 Mutations Presage CLL Rela...  english   \n",
       "1  Adalimumab Effective for Uveitis Associated wi...  english   \n",
       "2  Adalimumab Effective for Uveitis Associated wi...  english   \n",
       "\n",
       "                                          re_message  \n",
       "0  leukemia btk plcg2 mutations presage cll relap...  \n",
       "1  effective uveitis associated juvenile idiopath...  \n",
       "2  effective uveitis associated juvenile idiopath...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9434 9048\n"
     ]
    }
   ],
   "source": [
    "df_postncomment = pd.read_csv('twitter_preprocessing_utf16.csv', encoding = 'UTF-16LE', sep=',')\n",
    "#display(df_postncomment.head(5))\n",
    "df_english= df_postncomment.loc[df_postncomment['lang'] == 'english']\n",
    "#print(len(df_english['key']))\n",
    "df_rm = df_english.drop_duplicates(subset=['key','re_message'])\n",
    "display(df_rm.head(3))\n",
    "print(len(df_postncomment['key']),len(df_rm['key']))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>no</th>\n",
       "      <th>key</th>\n",
       "      <th>created_time</th>\n",
       "      <th>message</th>\n",
       "      <th>lang</th>\n",
       "      <th>re_message</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>ibrutinib</td>\n",
       "      <td>1/17/2003 0:03</td>\n",
       "      <td>#Leukemia BTK PLCG2 Mutations Presage CLL Rela...</td>\n",
       "      <td>english</td>\n",
       "      <td>leukemia btk plcg2 mutations presage cll relap...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "      <td>english</td>\n",
       "      <td>effective uveitis associated juvenile idiopath...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>adalimumab</td>\n",
       "      <td>1/17/2003 0:04</td>\n",
       "      <td>Adalimumab Effective for Uveitis Associated wi...</td>\n",
       "      <td>english</td>\n",
       "      <td>effective uveitis associated juvenile idiopath...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0  no         key    created_time  \\\n",
       "0           0   0   ibrutinib  1/17/2003 0:03   \n",
       "1           1   1  adalimumab  1/17/2003 0:04   \n",
       "2           2   2  adalimumab  1/17/2003 0:04   \n",
       "\n",
       "                                             message     lang  \\\n",
       "0  #Leukemia BTK PLCG2 Mutations Presage CLL Rela...  english   \n",
       "1  Adalimumab Effective for Uveitis Associated wi...  english   \n",
       "2  Adalimumab Effective for Uveitis Associated wi...  english   \n",
       "\n",
       "                                          re_message  \n",
       "0  leukemia btk plcg2 mutations presage cll relap...  \n",
       "1  effective uveitis associated juvenile idiopath...  \n",
       "2  effective uveitis associated juvenile idiopath...  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9048\n"
     ]
    }
   ],
   "source": [
    "rm_english_na = df_rm.dropna()\n",
    "#print(len(rm_english_na))\n",
    "dfinal_fb = pd.DataFrame(rm_english_na, columns = ['no','key', 'created_time','message','lang','re_message'])\n",
    "dfinal_fb.to_csv(\"final_twitter_preprocessing_utf16.csv\", encoding='UTF-16LE',columns = ['no','key', 'created_time','message','lang','re_message'])\n",
    "df_postn = pd.read_csv('final_twitter_preprocessing_utf16.csv', encoding = 'UTF-16LE', sep=',')\n",
    "display(df_postn.head(3))\n",
    "print(len(df_postn))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer, CountVectorizer\n",
    "#vectorizer = TfidfVectorizer(analyzer='word', ngram_range=(1,1), min_df = 0, stop_words = 'english')\n",
    "vectorizer = CountVectorizer(analyzer='word', ngram_range=(1,1), min_df = 0, stop_words = 'english')\n",
    "corpus=list(df_postn['re_message'])\n",
    "matrix =  vectorizer.fit_transform(corpus)\n",
    "feature_names = vectorizer.get_feature_names()\n",
    "#print(feature_names)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:lda:n_documents: 9048\n",
      "INFO:lda:vocab_size: 17562\n",
      "INFO:lda:n_words: 88326\n",
      "INFO:lda:n_topics: 30\n",
      "INFO:lda:n_iter: 500\n",
      "INFO:lda:<0> log likelihood: -1199174\n",
      "INFO:lda:<10> log likelihood: -791562\n",
      "INFO:lda:<20> log likelihood: -759313\n",
      "INFO:lda:<30> log likelihood: -748186\n",
      "INFO:lda:<40> log likelihood: -742239\n",
      "INFO:lda:<50> log likelihood: -737726\n",
      "INFO:lda:<60> log likelihood: -734430\n",
      "INFO:lda:<70> log likelihood: -732738\n",
      "INFO:lda:<80> log likelihood: -731160\n",
      "INFO:lda:<90> log likelihood: -729869\n",
      "INFO:lda:<100> log likelihood: -728915\n",
      "INFO:lda:<110> log likelihood: -727523\n",
      "INFO:lda:<120> log likelihood: -726709\n",
      "INFO:lda:<130> log likelihood: -726212\n",
      "INFO:lda:<140> log likelihood: -725666\n",
      "INFO:lda:<150> log likelihood: -725565\n",
      "INFO:lda:<160> log likelihood: -725221\n",
      "INFO:lda:<170> log likelihood: -725145\n",
      "INFO:lda:<180> log likelihood: -724641\n",
      "INFO:lda:<190> log likelihood: -723973\n",
      "INFO:lda:<200> log likelihood: -723760\n",
      "INFO:lda:<210> log likelihood: -723915\n",
      "INFO:lda:<220> log likelihood: -724076\n",
      "INFO:lda:<230> log likelihood: -723952\n",
      "INFO:lda:<240> log likelihood: -723608\n",
      "INFO:lda:<250> log likelihood: -723983\n",
      "INFO:lda:<260> log likelihood: -723912\n",
      "INFO:lda:<270> log likelihood: -723273\n",
      "INFO:lda:<280> log likelihood: -722950\n",
      "INFO:lda:<290> log likelihood: -723324\n",
      "INFO:lda:<300> log likelihood: -723231\n",
      "INFO:lda:<310> log likelihood: -722747\n",
      "INFO:lda:<320> log likelihood: -722442\n",
      "INFO:lda:<330> log likelihood: -722668\n",
      "INFO:lda:<340> log likelihood: -722978\n",
      "INFO:lda:<350> log likelihood: -722057\n",
      "INFO:lda:<360> log likelihood: -722380\n",
      "INFO:lda:<370> log likelihood: -722576\n",
      "INFO:lda:<380> log likelihood: -722346\n",
      "INFO:lda:<390> log likelihood: -722134\n",
      "INFO:lda:<400> log likelihood: -722521\n",
      "INFO:lda:<410> log likelihood: -722320\n",
      "INFO:lda:<420> log likelihood: -721932\n",
      "INFO:lda:<430> log likelihood: -722468\n",
      "INFO:lda:<440> log likelihood: -722487\n",
      "INFO:lda:<450> log likelihood: -721498\n",
      "INFO:lda:<460> log likelihood: -722030\n",
      "INFO:lda:<470> log likelihood: -721275\n",
      "INFO:lda:<480> log likelihood: -722216\n",
      "INFO:lda:<490> log likelihood: -721836\n",
      "INFO:lda:<499> log likelihood: -721315\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Topic 0: hcv patients twitter hepatitis cancer liver com href rel nofollow http treatment risk iphone download increased times testing non\n",
      "Topic 1: abbvie treatment positive opinion chmp receives week option brief viekirax hep opdivo hcv read enanta recommending project patients partner\n",
      "Topic 2: psoriasis humira fda severe abbvie fingernail data moderate approves addition adalimumab approval prescribing receive information abbvieäóťs goodwinlaw us_fda adding\n",
      "Topic 3: abbvie psoriasis thanks share help great community today latest hear living talk way people story npf learn small abbott\n",
      "Topic 4: ibrutinib study phase amgen tgtx cll sandoz data positive results risk patients iii ublituximab trial imbruvica case high announces\n",
      "Topic 5: adalimumab treatment patients therapy biosimilar uveitis european ibd prognosis choice commission tool disease approves new infliximab associated drug rheumatoidarthritis\n",
      "Topic 6: bristol myers squibb bmy read bristolmyerssquibb company oncology international network immuno expands bristolmyers present addition understanding icahn takeover advances\n",
      "Topic 7: abbvie research real pfizer world new know collaboration announce scholarship things analysis observational information program large companies network m2gen\n",
      "Topic 8: psoriasis skin eczema acne soap dry milk diseases cream tea scalp green ireland genetic buy rash crack inflammation hold\n",
      "Topic 9: arthritis rheumatoid pain symptoms new drug joint rheumatoidarthritis rheum fight swelling help including disease people treat common remedies psoriatic\n",
      "Topic 10: psoriasis new people best thank roots tumors lynch makes foods love fighting thomas post attacking eat outcomes join worst\n",
      "Topic 11: psoriasis signs merck treatment enbrel based avillion development deal therapy check pharma clinical value amgen life nanobody aad17 news\n",
      "Topic 12: humira know psoriasis time chronic continues let market need suffers attacked available pain commercial lady effects gaga make buy\n",
      "Topic 13: amgen global abbvie jobs manager marketing oaks health job director conference senior care sales associate usa medical chicago lgbtpro\n",
      "Topic 14: abbvie amgen hold humira stop patent vetr best abuse society rating vitamin linked autoimmune health deficiency review cfo abbv\n",
      "Topic 15: humira biosimilar study adalimumab efficacy europe phase approved shows psoriasis johnson head trial results meets guselkumab better superiority new\n",
      "Topic 16: abbvie abbv shares management llc stake position capital bought sells group review asset japan buys investment priority advisors corp\n",
      "Topic 17: spondylitis ankylosing imagine enbrel dragons dan reynolds outcomes youtube people contract health video spine pilgrim pain harvard ankylosingspondylitis issues\n",
      "Topic 18: new biosimilar efficacy sandoz adalimumab data equivalent proposed image engagement demonstrate oncologists overall genentech year franchise release medicine press\n",
      "Topic 19: arthritis rheumatoid disease anti inflammatory fatigue flares fight cookbook fibromyalgia recipes lupus autoimmune cause multiple tea health chronic heals\n",
      "Topic 20: abbvie abbv good value great company high stock market price stocks dividend nyse pharma overview risk gilead amgn growth\n",
      "Topic 21: amgen new research read approval data blog cancer american meeting drugs amgn annual clinicaltrials association work bmsnews highlight preclinical\n",
      "Topic 22: bristol myers squibb cancer bmy exelixis collaboration read trials bristolmyerssquibb new investment medicine clinical shares team grail chief trial\n",
      "Topic 23: humira enbrel like ve insurance month cost day years don injection good shot time injections today bad working remicade\n",
      "Topic 24: abbvie humira court today patents biologics high icymi biosimilars announced samsung brand fujifilm new janebrophyld seananstee salforduni burnhamformayor thercn\n",
      "Topic 25: ibrutinib cll patients chronic leukemia lymphocytic relapsed refractory lymphoma cell resistance treatment manage treated report new btk drug venetoclax\n",
      "Topic 26: hcv hepatitis hiv health free treatment diet care infection help virus access tips antibody suffer visit cure diseases technology\n",
      "Topic 27: arthritis rheumatoid abbvie heart learn health women risk know taking month patient drug used support dangerous drugs national article\n",
      "Topic 28: amgen study myeloma kyprolis seen velcade survival longer amgn quality reuters awards stage expand cancer care grant csr communities\n",
      "Topic 29: drug imbruvica humira sales meds long tgtx app therapy key astrazeneca use abbvie term combo make everyday care reminder\n"
     ]
    }
   ],
   "source": [
    "#The word corpus contained in each topic\n",
    "import numpy as np\n",
    "import lda\n",
    "vocab = feature_names\n",
    "model = lda.LDA(n_topics=30, n_iter=500, random_state=1)\n",
    "model.fit(matrix)\n",
    "topic_word = model.topic_word_\n",
    "n_top_words = 20\n",
    " \n",
    "for i, topic_dist in enumerate(topic_word):\n",
    "    topic_words = np.array(vocab)[np.argsort(topic_dist)][:-n_top_words:-1]\n",
    "    print('Topic {}: {}'.format(i, ' '.join(topic_words)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*Topic 1\n",
      "- hcv patients twitter hepatitis cancer\n",
      "*Topic 2\n",
      "- abbvie treatment positive opinion chmp\n",
      "*Topic 3\n",
      "- psoriasis humira fda severe abbvie\n",
      "*Topic 4\n",
      "- abbvie psoriasis thanks share help\n",
      "*Topic 5\n",
      "- ibrutinib study phase amgen tgtx\n",
      "*Topic 6\n",
      "- adalimumab treatment patients therapy biosimilar\n",
      "*Topic 7\n",
      "- bristol myers squibb bmy read\n",
      "*Topic 8\n",
      "- abbvie research real pfizer world\n",
      "*Topic 9\n",
      "- psoriasis skin eczema acne soap\n",
      "*Topic 10\n",
      "- arthritis rheumatoid pain symptoms new\n",
      "*Topic 11\n",
      "- psoriasis new people best thank\n",
      "*Topic 12\n",
      "- psoriasis signs merck treatment enbrel\n",
      "*Topic 13\n",
      "- humira know psoriasis time chronic\n",
      "*Topic 14\n",
      "- amgen global abbvie jobs manager\n",
      "*Topic 15\n",
      "- abbvie amgen hold humira stop\n",
      "*Topic 16\n",
      "- humira biosimilar study adalimumab efficacy\n",
      "*Topic 17\n",
      "- abbvie abbv shares management llc\n",
      "*Topic 18\n",
      "- spondylitis ankylosing imagine enbrel dragons\n",
      "*Topic 19\n",
      "- new biosimilar efficacy sandoz adalimumab\n",
      "*Topic 20\n",
      "- arthritis rheumatoid disease anti inflammatory\n",
      "*Topic 21\n",
      "- abbvie abbv good value great\n",
      "*Topic 22\n",
      "- amgen new research read approval\n",
      "*Topic 23\n",
      "- bristol myers squibb cancer bmy\n",
      "*Topic 24\n",
      "- humira enbrel like ve insurance\n",
      "*Topic 25\n",
      "- abbvie humira court today patents\n",
      "*Topic 26\n",
      "- ibrutinib cll patients chronic leukemia\n",
      "*Topic 27\n",
      "- hcv hepatitis hiv health free\n",
      "*Topic 28\n",
      "- arthritis rheumatoid abbvie heart learn\n",
      "*Topic 29\n",
      "- amgen study myeloma kyprolis seen\n",
      "*Topic 30\n",
      "- drug imbruvica humira sales meds\n"
     ]
    }
   ],
   "source": [
    "n=5\n",
    "for i, topic_dist in enumerate(topic_word):  \n",
    "    topic_words = np.array(vocab)[np.argsort(topic_dist)][:-(n+1):-1]  \n",
    "    print('*Topic {}\\n- {}'.format(i+1, ' '.join(topic_words)))  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "type(doc_topic): <class 'numpy.ndarray'>\n",
      "shape: (9048, 30)\n",
      "doc: 0 topic: 25\n",
      "doc: 1 topic: 5\n",
      "doc: 2 topic: 5\n",
      "doc: 3 topic: 6\n",
      "doc: 4 topic: 29\n",
      "doc: 5 topic: 27\n",
      "doc: 6 topic: 21\n",
      "doc: 7 topic: 17\n",
      "doc: 8 topic: 24\n",
      "doc: 9 topic: 22\n"
     ]
    }
   ],
   "source": [
    "doc_topic = model.doc_topic_  \n",
    "print(\"type(doc_topic): {}\".format(type(doc_topic)))  \n",
    "print(\"shape: {}\".format(doc_topic.shape))  \n",
    "for n in range(10):  \n",
    "    topic_most_pr = doc_topic[n].argmax()  \n",
    "    print(\"doc: {} topic: {}\".format(n, topic_most_pr)) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "from nltk.corpus import stopwords \n",
    "from nltk.stem.wordnet import WordNetLemmatizer\n",
    "import string\n",
    "stop = set(stopwords.words('english'))\n",
    "exclude = set(string.punctuation) \n",
    "lemma = WordNetLemmatizer()\n",
    "corpus=list(df_postn['re_message'])\n",
    "def clean(doc):\n",
    "    stop_free = \" \".join([i for i in doc.lower().split() if i not in stop])\n",
    "    punc_free = ''.join(ch for ch in stop_free if ch not in exclude)\n",
    "    normalized = \" \".join(lemma.lemmatize(word) for word in punc_free.split())\n",
    "    return normalized\n",
    "doc_clean = [doc.split() for doc in corpus]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:summa.preprocessing.cleaner:'pattern' package not found; tag filters are not available for English\n",
      "INFO:gensim.corpora.dictionary:adding document #0 to Dictionary(0 unique tokens: [])\n",
      "INFO:gensim.corpora.dictionary:built Dictionary(17959 unique tokens: ['leukemia', 'btk', 'plcg2', 'mutations', 'presage']...) from 9048 documents (total 92298 corpus positions)\n"
     ]
    }
   ],
   "source": [
    "# Importing Gensim\n",
    "import gensim\n",
    "from gensim import corpora\n",
    "\n",
    "# Creating the term dictionary of our courpus, where every unique term is assigned an index. \n",
    "dictionary = corpora.Dictionary(doc_clean)\n",
    "\n",
    "# Converting list of documents (corpus) into Document Term Matrix using dictionary prepared above.\n",
    "doc_term_matrix = [dictionary.doc2bow(doc) for doc in doc_clean]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:gensim.models.ldamodel:using symmetric alpha at 0.03333333333333333\n",
      "INFO:gensim.models.ldamodel:using symmetric eta at 5.5682387660782896e-05\n",
      "INFO:gensim.models.ldamodel:using serial LDA version on this node\n",
      "INFO:gensim.models.ldamodel:running online LDA training, 30 topics, 5 passes over the supplied corpus of 9048 documents, updating model once every 9048 documents, evaluating perplexity every 9048 documents, iterating 50x with a convergence threshold of 0.001000\n",
      "WARNING:gensim.models.ldamodel:too few updates, training might not converge; consider increasing the number of passes or iterations to improve accuracy\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #1000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #2000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #3000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #4000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #5000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #6000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #7000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #8000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #9000/9048\n",
      "INFO:gensim.models.ldamodel:-23.637 per-word bound, 13042961.0 perplexity estimate based on a held-out corpus of 48 documents with 446 words\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 0, at document #9048/9048\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.019*\"humira\" + 0.019*\"abbvie\" + 0.017*\"bristol\" + 0.016*\"myers\" + 0.014*\"squibb\" + 0.009*\"psoriasis\" + 0.007*\"bmy\" + 0.006*\"abbv\" + 0.005*\"inc\" + 0.005*\"biosimilar\"\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.018*\"arthritis\" + 0.016*\"humira\" + 0.016*\"rheumatoid\" + 0.013*\"new\" + 0.011*\"abbvie\" + 0.008*\"inc\" + 0.006*\"hcv\" + 0.005*\"amgen\" + 0.005*\"abbv\" + 0.005*\"therapy\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.024*\"bristol\" + 0.022*\"myers\" + 0.021*\"abbvie\" + 0.017*\"squibb\" + 0.010*\"inc\" + 0.007*\"abbv\" + 0.007*\"bmy\" + 0.007*\"psoriasis\" + 0.006*\"cancer\" + 0.006*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.016*\"arthritis\" + 0.015*\"rheumatoid\" + 0.014*\"squibb\" + 0.014*\"bristol\" + 0.013*\"myers\" + 0.011*\"bmy\" + 0.010*\"psoriasis\" + 0.010*\"read\" + 0.009*\"abbvie\" + 0.008*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.014*\"abbvie\" + 0.009*\"amgen\" + 0.008*\"arthritis\" + 0.008*\"humira\" + 0.007*\"rheumatoid\" + 0.006*\"myers\" + 0.006*\"bristol\" + 0.006*\"psoriasis\" + 0.005*\"squibb\" + 0.004*\"drug\"\n",
      "INFO:gensim.models.ldamodel:topic diff=25.827048, rho=1.000000\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #1000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #2000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #3000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #4000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #5000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #6000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #7000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #8000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #9000/9048\n",
      "INFO:gensim.models.ldamodel:-9.523 per-word bound, 736.0 perplexity estimate based on a held-out corpus of 48 documents with 446 words\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 1, at document #9048/9048\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.023*\"arthritis\" + 0.021*\"rheumatoid\" + 0.013*\"abbvie\" + 0.012*\"ibrutinib\" + 0.009*\"new\" + 0.008*\"cll\" + 0.008*\"patients\" + 0.007*\"humira\" + 0.007*\"psoriasis\" + 0.007*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.028*\"bristol\" + 0.026*\"myers\" + 0.022*\"abbvie\" + 0.019*\"squibb\" + 0.010*\"inc\" + 0.008*\"cancer\" + 0.008*\"bmy\" + 0.008*\"abbv\" + 0.006*\"read\" + 0.006*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.020*\"humira\" + 0.019*\"abbvie\" + 0.018*\"bristol\" + 0.017*\"myers\" + 0.015*\"squibb\" + 0.008*\"psoriasis\" + 0.008*\"bmy\" + 0.006*\"patents\" + 0.006*\"court\" + 0.006*\"abbv\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.022*\"psoriasis\" + 0.015*\"bristol\" + 0.015*\"humira\" + 0.013*\"arthritis\" + 0.013*\"myers\" + 0.011*\"rheumatoid\" + 0.011*\"squibb\" + 0.009*\"know\" + 0.008*\"spondylitis\" + 0.008*\"ankylosing\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.017*\"arthritis\" + 0.014*\"psoriasis\" + 0.013*\"rheumatoid\" + 0.013*\"humira\" + 0.012*\"amgen\" + 0.008*\"marketing\" + 0.007*\"oaks\" + 0.007*\"jobs\" + 0.006*\"enbrel\" + 0.005*\"via\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.038975, rho=0.300856\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #1000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #2000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #3000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #4000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #5000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #6000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #7000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #8000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #9000/9048\n",
      "INFO:gensim.models.ldamodel:-9.360 per-word bound, 657.1 perplexity estimate based on a held-out corpus of 48 documents with 446 words\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 2, at document #9048/9048\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.021*\"bristol\" + 0.020*\"myers\" + 0.017*\"squibb\" + 0.012*\"humira\" + 0.010*\"hcv\" + 0.009*\"arthritis\" + 0.008*\"rheumatoid\" + 0.008*\"abbvie\" + 0.008*\"bmy\" + 0.006*\"adalimumab\"\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.019*\"arthritis\" + 0.017*\"rheumatoid\" + 0.015*\"abbvie\" + 0.012*\"ibrutinib\" + 0.010*\"good\" + 0.009*\"drug\" + 0.009*\"psoriasis\" + 0.009*\"patients\" + 0.008*\"company\" + 0.008*\"value\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.028*\"arthritis\" + 0.027*\"rheumatoid\" + 0.017*\"drug\" + 0.016*\"new\" + 0.014*\"pain\" + 0.012*\"humira\" + 0.011*\"could\" + 0.011*\"abbvie\" + 0.009*\"symptoms\" + 0.009*\"joint\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.015*\"abbvie\" + 0.010*\"amgen\" + 0.008*\"humira\" + 0.007*\"arthritis\" + 0.006*\"rheumatoid\" + 0.005*\"psoriasis\" + 0.005*\"drug\" + 0.004*\"hcv\" + 0.004*\"myers\" + 0.004*\"bristol\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.020*\"abbvie\" + 0.019*\"arthritis\" + 0.016*\"inc\" + 0.015*\"rheumatoid\" + 0.011*\"abbv\" + 0.010*\"treatment\" + 0.010*\"hcv\" + 0.007*\"patients\" + 0.007*\"psoriasis\" + 0.006*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.042010, rho=0.288100\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #1000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #2000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #3000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #4000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #5000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #6000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #7000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #8000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #9000/9048\n",
      "INFO:gensim.models.ldamodel:-9.245 per-word bound, 606.6 perplexity estimate based on a held-out corpus of 48 documents with 446 words\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 3, at document #9048/9048\n",
      "INFO:gensim.models.ldamodel:topic #22 (0.033): 0.029*\"abbvie\" + 0.009*\"humira\" + 0.009*\"sales\" + 0.008*\"imbruvica\" + 0.008*\"abbv\" + 0.008*\"arthritis\" + 0.007*\"opinion\" + 0.007*\"positive\" + 0.007*\"rheumatoid\" + 0.006*\"amgen\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.022*\"treatment\" + 0.019*\"positive\" + 0.019*\"opinion\" + 0.017*\"chmp\" + 0.017*\"abbvie\" + 0.017*\"receives\" + 0.011*\"week\" + 0.011*\"option\" + 0.010*\"viekirax\" + 0.009*\"health\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.026*\"psoriasis\" + 0.023*\"arthritis\" + 0.022*\"rheumatoid\" + 0.017*\"study\" + 0.011*\"kyprolis\" + 0.011*\"velcade\" + 0.011*\"myeloma\" + 0.011*\"amgen's\" + 0.010*\"survival\" + 0.010*\"seen\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.023*\"psoriasis\" + 0.015*\"humira\" + 0.014*\"arthritis\" + 0.013*\"bristol\" + 0.012*\"rheumatoid\" + 0.011*\"know\" + 0.011*\"myers\" + 0.009*\"spondylitis\" + 0.009*\"ankylosing\" + 0.009*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.022*\"humira\" + 0.019*\"abbvie\" + 0.013*\"psoriasis\" + 0.011*\"abbv\" + 0.009*\"inc\" + 0.008*\"study\" + 0.008*\"phase\" + 0.006*\"efficacy\" + 0.005*\"ankylosing\" + 0.005*\"spondylitis\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.043088, rho=0.276839\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #1000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #2000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #3000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #4000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #5000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #6000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #7000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #8000/9048\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #9000/9048\n",
      "INFO:gensim.models.ldamodel:-9.164 per-word bound, 573.8 perplexity estimate based on a held-out corpus of 48 documents with 446 words\n",
      "INFO:gensim.models.ldamodel:PROGRESS: pass 4, at document #9048/9048\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.025*\"bristol\" + 0.024*\"myers\" + 0.018*\"squibb\" + 0.018*\"psoriasis\" + 0.016*\"arthritis\" + 0.013*\"rheumatoid\" + 0.011*\"amgen\" + 0.007*\"abbvie\" + 0.006*\"investment\" + 0.006*\"medicine\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.018*\"abbvie\" + 0.012*\"arthritis\" + 0.011*\"rheumatoid\" + 0.011*\"humira\" + 0.010*\"treatment\" + 0.010*\"psoriasis\" + 0.008*\"could\" + 0.007*\"hcv\" + 0.007*\"review\" + 0.007*\"priority\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.015*\"abbvie\" + 0.011*\"amgen\" + 0.008*\"humira\" + 0.006*\"arthritis\" + 0.005*\"rheumatoid\" + 0.005*\"drug\" + 0.005*\"hcv\" + 0.004*\"psoriasis\" + 0.004*\"patients\" + 0.004*\"testing\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.023*\"humira\" + 0.019*\"abbvie\" + 0.013*\"psoriasis\" + 0.011*\"abbv\" + 0.009*\"inc\" + 0.009*\"phase\" + 0.008*\"study\" + 0.007*\"efficacy\" + 0.006*\"guselkumab\" + 0.006*\"superiority\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.021*\"humira\" + 0.009*\"drug\" + 0.008*\"arthritis\" + 0.008*\"study\" + 0.007*\"rheumatoid\" + 0.007*\"psoriasis\" + 0.005*\"via\" + 0.005*\"abbvie\" + 0.005*\"seen\" + 0.005*\"survival\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.043595, rho=0.266804\n"
     ]
    }
   ],
   "source": [
    "# Creating the object for LDA model using gensim library\n",
    "Lda = gensim.models.ldamodel.LdaModel\n",
    "\n",
    "# Running and Trainign LDA model on the document term matrix.\n",
    "#ldamodel = Lda(doc_term_matrix, num_topics=20, id2word = dictionary, passes=20)\n",
    "ldamodel = Lda(doc_term_matrix, num_topics=30, id2word = dictionary, update_every=10, chunksize=1000, passes=5)\n",
    "#lda.printTopics(k)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:gensim.models.ldamodel:topic #0 (0.033): 0.030*\"arthritis\" + 0.025*\"rheumatoid\" + 0.015*\"humira\" + 0.013*\"psoriasis\" + 0.011*\"amgen\" + 0.009*\"enbrel\" + 0.007*\"signs\" + 0.006*\"based\" + 0.006*\"deal\" + 0.005*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.023*\"humira\" + 0.019*\"abbvie\" + 0.013*\"psoriasis\" + 0.011*\"abbv\" + 0.009*\"inc\" + 0.009*\"phase\" + 0.008*\"study\" + 0.007*\"efficacy\" + 0.006*\"guselkumab\" + 0.006*\"superiority\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.026*\"arthritis\" + 0.024*\"rheumatoid\" + 0.021*\"ibrutinib\" + 0.013*\"new\" + 0.013*\"cll\" + 0.009*\"chronic\" + 0.009*\"abbvie\" + 0.009*\"patients\" + 0.009*\"data\" + 0.008*\"cancer\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.020*\"abbvie\" + 0.018*\"arthritis\" + 0.016*\"inc\" + 0.015*\"rheumatoid\" + 0.012*\"hcv\" + 0.011*\"abbv\" + 0.011*\"treatment\" + 0.008*\"patients\" + 0.007*\"twitter\" + 0.006*\"skin\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.063*\"bristol\" + 0.060*\"myers\" + 0.052*\"squibb\" + 0.019*\"bmy\" + 0.013*\"oncology\" + 0.012*\"immuno\" + 0.011*\"humira\" + 0.011*\"international\" + 0.010*\"new\" + 0.010*\"network\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.022*\"humira\" + 0.018*\"arthritis\" + 0.017*\"rheumatoid\" + 0.012*\"biosimilar\" + 0.008*\"amgen\" + 0.008*\"ibrutinib\" + 0.007*\"hcv\" + 0.007*\"europe\" + 0.006*\"adalimumab\" + 0.006*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #6 (0.033): 0.026*\"bristol\" + 0.024*\"myers\" + 0.023*\"bmy\" + 0.018*\"squibb\" + 0.016*\"humira\" + 0.015*\"read\" + 0.013*\"bristolmyerssquibb\" + 0.009*\"psoriasis\" + 0.008*\"abbvie\" + 0.008*\"arthritis\"\n",
      "INFO:gensim.models.ldamodel:topic #7 (0.033): 0.023*\"psoriasis\" + 0.015*\"hcv\" + 0.014*\"abbvie\" + 0.012*\"treatment\" + 0.007*\"humira\" + 0.007*\"cancer\" + 0.007*\"patients\" + 0.007*\"skin\" + 0.006*\"arthritis\" + 0.005*\"liver\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.024*\"treatment\" + 0.022*\"positive\" + 0.021*\"opinion\" + 0.020*\"chmp\" + 0.019*\"receives\" + 0.018*\"abbvie\" + 0.013*\"week\" + 0.012*\"option\" + 0.010*\"viekirax\" + 0.009*\"health\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.025*\"arthritis\" + 0.024*\"rheumatoid\" + 0.013*\"disease\" + 0.012*\"autoimmune\" + 0.010*\"abbvie\" + 0.009*\"best\" + 0.008*\"ankylosing\" + 0.008*\"linked\" + 0.008*\"deficiency\" + 0.008*\"spondylitis\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.021*\"bristol\" + 0.020*\"myers\" + 0.017*\"squibb\" + 0.012*\"hcv\" + 0.012*\"humira\" + 0.007*\"arthritis\" + 0.007*\"abbvie\" + 0.007*\"bmy\" + 0.006*\"rheumatoid\" + 0.006*\"adalimumab\"\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.023*\"arthritis\" + 0.021*\"rheumatoid\" + 0.018*\"new\" + 0.018*\"humira\" + 0.013*\"therapy\" + 0.011*\"tool\" + 0.010*\"abbvie\" + 0.009*\"choice\" + 0.009*\"prognosis\" + 0.007*\"hcv\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.019*\"spondylitis\" + 0.018*\"abbvie\" + 0.018*\"ankylosing\" + 0.013*\"humira\" + 0.011*\"psoriasis\" + 0.010*\"patent\" + 0.010*\"abuse\" + 0.009*\"society\" + 0.009*\"stop\" + 0.008*\"abbv\"\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.023*\"abbvie\" + 0.016*\"arthritis\" + 0.015*\"rheumatoid\" + 0.015*\"amgen\" + 0.014*\"psoriasis\" + 0.010*\"inc\" + 0.007*\"bristol\" + 0.007*\"amgn\" + 0.006*\"myers\" + 0.006*\"bmy\"\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.022*\"abbvie\" + 0.016*\"new\" + 0.012*\"collaboration\" + 0.011*\"research\" + 0.010*\"today\" + 0.009*\"inc\" + 0.009*\"announce\" + 0.008*\"enbrel\" + 0.008*\"humira\" + 0.007*\"m2gen\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.018*\"abbvie\" + 0.012*\"arthritis\" + 0.011*\"rheumatoid\" + 0.011*\"humira\" + 0.010*\"treatment\" + 0.010*\"psoriasis\" + 0.008*\"could\" + 0.007*\"hcv\" + 0.007*\"review\" + 0.007*\"priority\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.023*\"psoriasis\" + 0.015*\"humira\" + 0.014*\"arthritis\" + 0.012*\"know\" + 0.012*\"rheumatoid\" + 0.011*\"bristol\" + 0.010*\"spondylitis\" + 0.010*\"ankylosing\" + 0.009*\"myers\" + 0.007*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.023*\"humira\" + 0.020*\"abbvie\" + 0.016*\"bristol\" + 0.016*\"squibb\" + 0.016*\"myers\" + 0.011*\"court\" + 0.010*\"patents\" + 0.009*\"bmy\" + 0.007*\"stage\" + 0.007*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.048*\"abbvie\" + 0.033*\"inc\" + 0.026*\"abbv\" + 0.019*\"arthritis\" + 0.017*\"rheumatoid\" + 0.011*\"humira\" + 0.009*\"management\" + 0.009*\"position\" + 0.008*\"stake\" + 0.007*\"llc\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.027*\"psoriasis\" + 0.023*\"arthritis\" + 0.022*\"rheumatoid\" + 0.020*\"study\" + 0.014*\"kyprolis\" + 0.013*\"velcade\" + 0.013*\"myeloma\" + 0.013*\"amgen's\" + 0.012*\"survival\" + 0.012*\"longer\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.021*\"humira\" + 0.009*\"drug\" + 0.008*\"arthritis\" + 0.008*\"study\" + 0.007*\"rheumatoid\" + 0.007*\"psoriasis\" + 0.005*\"via\" + 0.005*\"abbvie\" + 0.005*\"seen\" + 0.005*\"survival\"\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.020*\"arthritis\" + 0.018*\"rheumatoid\" + 0.015*\"abbvie\" + 0.014*\"ibrutinib\" + 0.014*\"good\" + 0.010*\"value\" + 0.010*\"patients\" + 0.010*\"company\" + 0.009*\"drug\" + 0.009*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #22 (0.033): 0.030*\"abbvie\" + 0.010*\"sales\" + 0.010*\"imbruvica\" + 0.010*\"humira\" + 0.008*\"abbv\" + 0.007*\"arthritis\" + 0.007*\"opinion\" + 0.007*\"positive\" + 0.007*\"continues\" + 0.007*\"hep\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.015*\"abbvie\" + 0.011*\"amgen\" + 0.008*\"humira\" + 0.006*\"arthritis\" + 0.005*\"rheumatoid\" + 0.005*\"drug\" + 0.005*\"hcv\" + 0.004*\"psoriasis\" + 0.004*\"patients\" + 0.004*\"testing\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.028*\"psoriasis\" + 0.022*\"approves\" + 0.021*\"fda\" + 0.020*\"severe\" + 0.020*\"moderate\" + 0.020*\"addition\" + 0.019*\"data\" + 0.019*\"fingernail\" + 0.016*\"abbvie\" + 0.015*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.025*\"bristol\" + 0.024*\"myers\" + 0.018*\"squibb\" + 0.018*\"psoriasis\" + 0.016*\"arthritis\" + 0.013*\"rheumatoid\" + 0.011*\"amgen\" + 0.007*\"abbvie\" + 0.006*\"investment\" + 0.006*\"medicine\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.034*\"bristol\" + 0.033*\"myers\" + 0.024*\"abbvie\" + 0.022*\"squibb\" + 0.012*\"cancer\" + 0.009*\"bmy\" + 0.009*\"exelixis\" + 0.008*\"inc\" + 0.008*\"trials\" + 0.008*\"shares\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.035*\"arthritis\" + 0.033*\"rheumatoid\" + 0.020*\"drug\" + 0.020*\"pain\" + 0.017*\"new\" + 0.014*\"could\" + 0.012*\"symptoms\" + 0.012*\"joint\" + 0.011*\"humira\" + 0.009*\"abbvie\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.017*\"amgen\" + 0.017*\"psoriasis\" + 0.016*\"arthritis\" + 0.015*\"humira\" + 0.012*\"rheumatoid\" + 0.011*\"jobs\" + 0.011*\"marketing\" + 0.010*\"oaks\" + 0.008*\"first\" + 0.007*\"approval\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.023*\"squibb\" + 0.021*\"bmy\" + 0.020*\"bristol\" + 0.020*\"myers\" + 0.016*\"read\" + 0.012*\"bristolmyerssquibb\" + 0.012*\"arthritis\" + 0.012*\"rheumatoid\" + 0.010*\"shares\" + 0.008*\"psoriasis\"\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[(0,\n",
       "  '0.030*\"arthritis\" + 0.025*\"rheumatoid\" + 0.015*\"humira\" + 0.013*\"psoriasis\" + 0.011*\"amgen\" + 0.009*\"enbrel\" + 0.007*\"signs\" + 0.006*\"based\" + 0.006*\"deal\" + 0.005*\"squibb\"'),\n",
       " (1,\n",
       "  '0.023*\"humira\" + 0.019*\"abbvie\" + 0.013*\"psoriasis\" + 0.011*\"abbv\" + 0.009*\"inc\" + 0.009*\"phase\" + 0.008*\"study\" + 0.007*\"efficacy\" + 0.006*\"guselkumab\" + 0.006*\"superiority\"'),\n",
       " (2,\n",
       "  '0.026*\"arthritis\" + 0.024*\"rheumatoid\" + 0.021*\"ibrutinib\" + 0.013*\"new\" + 0.013*\"cll\" + 0.009*\"chronic\" + 0.009*\"abbvie\" + 0.009*\"patients\" + 0.009*\"data\" + 0.008*\"cancer\"'),\n",
       " (3,\n",
       "  '0.020*\"abbvie\" + 0.018*\"arthritis\" + 0.016*\"inc\" + 0.015*\"rheumatoid\" + 0.012*\"hcv\" + 0.011*\"abbv\" + 0.011*\"treatment\" + 0.008*\"patients\" + 0.007*\"twitter\" + 0.006*\"skin\"'),\n",
       " (4,\n",
       "  '0.063*\"bristol\" + 0.060*\"myers\" + 0.052*\"squibb\" + 0.019*\"bmy\" + 0.013*\"oncology\" + 0.012*\"immuno\" + 0.011*\"humira\" + 0.011*\"international\" + 0.010*\"new\" + 0.010*\"network\"'),\n",
       " (5,\n",
       "  '0.022*\"humira\" + 0.018*\"arthritis\" + 0.017*\"rheumatoid\" + 0.012*\"biosimilar\" + 0.008*\"amgen\" + 0.008*\"ibrutinib\" + 0.007*\"hcv\" + 0.007*\"europe\" + 0.006*\"adalimumab\" + 0.006*\"psoriasis\"'),\n",
       " (6,\n",
       "  '0.026*\"bristol\" + 0.024*\"myers\" + 0.023*\"bmy\" + 0.018*\"squibb\" + 0.016*\"humira\" + 0.015*\"read\" + 0.013*\"bristolmyerssquibb\" + 0.009*\"psoriasis\" + 0.008*\"abbvie\" + 0.008*\"arthritis\"'),\n",
       " (7,\n",
       "  '0.023*\"psoriasis\" + 0.015*\"hcv\" + 0.014*\"abbvie\" + 0.012*\"treatment\" + 0.007*\"humira\" + 0.007*\"cancer\" + 0.007*\"patients\" + 0.007*\"skin\" + 0.006*\"arthritis\" + 0.005*\"liver\"'),\n",
       " (8,\n",
       "  '0.024*\"treatment\" + 0.022*\"positive\" + 0.021*\"opinion\" + 0.020*\"chmp\" + 0.019*\"receives\" + 0.018*\"abbvie\" + 0.013*\"week\" + 0.012*\"option\" + 0.010*\"viekirax\" + 0.009*\"health\"'),\n",
       " (9,\n",
       "  '0.025*\"arthritis\" + 0.024*\"rheumatoid\" + 0.013*\"disease\" + 0.012*\"autoimmune\" + 0.010*\"abbvie\" + 0.009*\"best\" + 0.008*\"ankylosing\" + 0.008*\"linked\" + 0.008*\"deficiency\" + 0.008*\"spondylitis\"'),\n",
       " (10,\n",
       "  '0.021*\"bristol\" + 0.020*\"myers\" + 0.017*\"squibb\" + 0.012*\"hcv\" + 0.012*\"humira\" + 0.007*\"arthritis\" + 0.007*\"abbvie\" + 0.007*\"bmy\" + 0.006*\"rheumatoid\" + 0.006*\"adalimumab\"'),\n",
       " (11,\n",
       "  '0.023*\"arthritis\" + 0.021*\"rheumatoid\" + 0.018*\"new\" + 0.018*\"humira\" + 0.013*\"therapy\" + 0.011*\"tool\" + 0.010*\"abbvie\" + 0.009*\"choice\" + 0.009*\"prognosis\" + 0.007*\"hcv\"'),\n",
       " (12,\n",
       "  '0.019*\"spondylitis\" + 0.018*\"abbvie\" + 0.018*\"ankylosing\" + 0.013*\"humira\" + 0.011*\"psoriasis\" + 0.010*\"patent\" + 0.010*\"abuse\" + 0.009*\"society\" + 0.009*\"stop\" + 0.008*\"abbv\"'),\n",
       " (13,\n",
       "  '0.023*\"abbvie\" + 0.016*\"arthritis\" + 0.015*\"rheumatoid\" + 0.015*\"amgen\" + 0.014*\"psoriasis\" + 0.010*\"inc\" + 0.007*\"bristol\" + 0.007*\"amgn\" + 0.006*\"myers\" + 0.006*\"bmy\"'),\n",
       " (14,\n",
       "  '0.022*\"abbvie\" + 0.016*\"new\" + 0.012*\"collaboration\" + 0.011*\"research\" + 0.010*\"today\" + 0.009*\"inc\" + 0.009*\"announce\" + 0.008*\"enbrel\" + 0.008*\"humira\" + 0.007*\"m2gen\"'),\n",
       " (15,\n",
       "  '0.018*\"abbvie\" + 0.012*\"arthritis\" + 0.011*\"rheumatoid\" + 0.011*\"humira\" + 0.010*\"treatment\" + 0.010*\"psoriasis\" + 0.008*\"could\" + 0.007*\"hcv\" + 0.007*\"review\" + 0.007*\"priority\"'),\n",
       " (16,\n",
       "  '0.023*\"psoriasis\" + 0.015*\"humira\" + 0.014*\"arthritis\" + 0.012*\"know\" + 0.012*\"rheumatoid\" + 0.011*\"bristol\" + 0.010*\"spondylitis\" + 0.010*\"ankylosing\" + 0.009*\"myers\" + 0.007*\"squibb\"'),\n",
       " (17,\n",
       "  '0.023*\"humira\" + 0.020*\"abbvie\" + 0.016*\"bristol\" + 0.016*\"squibb\" + 0.016*\"myers\" + 0.011*\"court\" + 0.010*\"patents\" + 0.009*\"bmy\" + 0.007*\"stage\" + 0.007*\"psoriasis\"'),\n",
       " (18,\n",
       "  '0.048*\"abbvie\" + 0.033*\"inc\" + 0.026*\"abbv\" + 0.019*\"arthritis\" + 0.017*\"rheumatoid\" + 0.011*\"humira\" + 0.009*\"management\" + 0.009*\"position\" + 0.008*\"stake\" + 0.007*\"llc\"'),\n",
       " (19,\n",
       "  '0.027*\"psoriasis\" + 0.023*\"arthritis\" + 0.022*\"rheumatoid\" + 0.020*\"study\" + 0.014*\"kyprolis\" + 0.013*\"velcade\" + 0.013*\"myeloma\" + 0.013*\"amgen\\'s\" + 0.012*\"survival\" + 0.012*\"longer\"'),\n",
       " (20,\n",
       "  '0.021*\"humira\" + 0.009*\"drug\" + 0.008*\"arthritis\" + 0.008*\"study\" + 0.007*\"rheumatoid\" + 0.007*\"psoriasis\" + 0.005*\"via\" + 0.005*\"abbvie\" + 0.005*\"seen\" + 0.005*\"survival\"'),\n",
       " (21,\n",
       "  '0.020*\"arthritis\" + 0.018*\"rheumatoid\" + 0.015*\"abbvie\" + 0.014*\"ibrutinib\" + 0.014*\"good\" + 0.010*\"value\" + 0.010*\"patients\" + 0.010*\"company\" + 0.009*\"drug\" + 0.009*\"psoriasis\"'),\n",
       " (22,\n",
       "  '0.030*\"abbvie\" + 0.010*\"sales\" + 0.010*\"imbruvica\" + 0.010*\"humira\" + 0.008*\"abbv\" + 0.007*\"arthritis\" + 0.007*\"opinion\" + 0.007*\"positive\" + 0.007*\"continues\" + 0.007*\"hep\"'),\n",
       " (23,\n",
       "  '0.015*\"abbvie\" + 0.011*\"amgen\" + 0.008*\"humira\" + 0.006*\"arthritis\" + 0.005*\"rheumatoid\" + 0.005*\"drug\" + 0.005*\"hcv\" + 0.004*\"psoriasis\" + 0.004*\"patients\" + 0.004*\"testing\"'),\n",
       " (24,\n",
       "  '0.028*\"psoriasis\" + 0.022*\"approves\" + 0.021*\"fda\" + 0.020*\"severe\" + 0.020*\"moderate\" + 0.020*\"addition\" + 0.019*\"data\" + 0.019*\"fingernail\" + 0.016*\"abbvie\" + 0.015*\"humira\"'),\n",
       " (25,\n",
       "  '0.025*\"bristol\" + 0.024*\"myers\" + 0.018*\"squibb\" + 0.018*\"psoriasis\" + 0.016*\"arthritis\" + 0.013*\"rheumatoid\" + 0.011*\"amgen\" + 0.007*\"abbvie\" + 0.006*\"investment\" + 0.006*\"medicine\"'),\n",
       " (26,\n",
       "  '0.034*\"bristol\" + 0.033*\"myers\" + 0.024*\"abbvie\" + 0.022*\"squibb\" + 0.012*\"cancer\" + 0.009*\"bmy\" + 0.009*\"exelixis\" + 0.008*\"inc\" + 0.008*\"trials\" + 0.008*\"shares\"'),\n",
       " (27,\n",
       "  '0.035*\"arthritis\" + 0.033*\"rheumatoid\" + 0.020*\"drug\" + 0.020*\"pain\" + 0.017*\"new\" + 0.014*\"could\" + 0.012*\"symptoms\" + 0.012*\"joint\" + 0.011*\"humira\" + 0.009*\"abbvie\"'),\n",
       " (28,\n",
       "  '0.017*\"amgen\" + 0.017*\"psoriasis\" + 0.016*\"arthritis\" + 0.015*\"humira\" + 0.012*\"rheumatoid\" + 0.011*\"jobs\" + 0.011*\"marketing\" + 0.010*\"oaks\" + 0.008*\"first\" + 0.007*\"approval\"'),\n",
       " (29,\n",
       "  '0.023*\"squibb\" + 0.021*\"bmy\" + 0.020*\"bristol\" + 0.020*\"myers\" + 0.016*\"read\" + 0.012*\"bristolmyerssquibb\" + 0.012*\"arthritis\" + 0.012*\"rheumatoid\" + 0.010*\"shares\" + 0.008*\"psoriasis\"')]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ldamodel.print_topics(30,10)\n",
    "#for topic in ldamodel:\n",
    "#    print(\"%s\\t%f\\n\"%(ldamodel.print_topic(topic[0]), topic[1]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:gensim.corpora.dictionary:adding document #0 to Dictionary(0 unique tokens: [])\n",
      "INFO:gensim.corpora.dictionary:built Dictionary(17959 unique tokens: ['leukemia', 'btk', 'plcg2', 'mutations', 'presage']...) from 9048 documents (total 92298 corpus positions)\n",
      "INFO:gensim.corpora.dictionary:discarding 15276 tokens: [('presage', 3), ('skuervxigz', 1), ('b98qx7la2p', 1), ('kerxhgapek', 1), ('abstracts', 1), ('accepted', 2), ('smzxvx9mda', 1), ('marianne', 1), ('humera', 1), ('ucäó_', 1)]...\n",
      "INFO:gensim.corpora.dictionary:keeping 2683 tokens which were in no less than 5 and no more than 8143 (=90.0%) documents\n",
      "INFO:gensim.corpora.dictionary:resulting dictionary: Dictionary(2683 unique tokens: ['leukemia', 'btk', 'plcg2', 'mutations', 'cll']...)\n",
      "INFO:gensim.models.ldamodel:using symmetric alpha at 0.03333333333333333\n",
      "INFO:gensim.models.ldamodel:using symmetric eta at 0.0003727171077152441\n",
      "INFO:gensim.models.ldamodel:using serial LDA version on this node\n",
      "INFO:gensim.models.ldamulticore:running online LDA training, 30 topics, 10 passes over the supplied corpus of 9048 documents, updating every 4000 documents, evaluating every ~9048 documents, iterating 50x with a convergence threshold of 0.001000\n",
      "INFO:gensim.models.ldamulticore:training LDA model using 4 processes\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 0, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.026*\"abbvie\" + 0.019*\"amgen\" + 0.018*\"myers\" + 0.018*\"bristol\" + 0.018*\"inc\" + 0.017*\"abbv\" + 0.016*\"drug\" + 0.016*\"ibrutinib\" + 0.013*\"squibb\" + 0.013*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.031*\"bristol\" + 0.031*\"myers\" + 0.029*\"abbvie\" + 0.024*\"squibb\" + 0.022*\"bmy\" + 0.020*\"inc\" + 0.013*\"amgen\" + 0.009*\"ibrutinib\" + 0.008*\"stake\" + 0.008*\"johnson\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.043*\"abbvie\" + 0.023*\"humira\" + 0.021*\"squibb\" + 0.018*\"myers\" + 0.018*\"bristol\" + 0.011*\"hcv\" + 0.008*\"new\" + 0.008*\"treatment\" + 0.007*\"clinical\" + 0.007*\"collaboration\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.028*\"humira\" + 0.021*\"study\" + 0.019*\"abbvie\" + 0.017*\"myers\" + 0.017*\"bristol\" + 0.014*\"amgen's\" + 0.014*\"myeloma\" + 0.013*\"squibb\" + 0.013*\"seen\" + 0.013*\"survival\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.021*\"bristol\" + 0.019*\"humira\" + 0.018*\"myers\" + 0.016*\"squibb\" + 0.015*\"new\" + 0.013*\"abbvie\" + 0.011*\"hcv\" + 0.011*\"adalimumab\" + 0.009*\"care\" + 0.009*\"like\"\n",
      "INFO:gensim.models.ldamodel:topic diff=24.342102, rho=1.000000\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.029*\"abbvie\" + 0.019*\"amgen\" + 0.017*\"humira\" + 0.014*\"good\" + 0.013*\"psoriasis\" + 0.013*\"arthritis\" + 0.012*\"amgn\" + 0.010*\"rheumatoid\" + 0.010*\"company\" + 0.010*\"value\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.049*\"bristol\" + 0.049*\"myers\" + 0.047*\"squibb\" + 0.019*\"abbvie\" + 0.014*\"bmy\" + 0.013*\"oncology\" + 0.013*\"expands\" + 0.012*\"network\" + 0.012*\"international\" + 0.011*\"immuno\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.019*\"hcv\" + 0.019*\"cancer\" + 0.014*\"psoriasis\" + 0.014*\"arthritis\" + 0.014*\"bristol\" + 0.013*\"adalimumab\" + 0.013*\"rheumatoid\" + 0.013*\"myers\" + 0.011*\"humira\" + 0.010*\"abbvie\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.029*\"abbvie\" + 0.020*\"humira\" + 0.014*\"squibb\" + 0.013*\"bristol\" + 0.013*\"abbv\" + 0.012*\"enbrel\" + 0.012*\"myers\" + 0.009*\"inc\" + 0.009*\"bmy\" + 0.008*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.033*\"abbvie\" + 0.026*\"humira\" + 0.012*\"myers\" + 0.012*\"bristol\" + 0.011*\"enbrel\" + 0.010*\"squibb\" + 0.010*\"drug\" + 0.009*\"amgen\" + 0.009*\"arthritis\" + 0.008*\"bmy\"\n",
      "INFO:gensim.models.ldamodel:topic diff=3.805742, rho=0.447214\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.035*\"bristol\" + 0.033*\"myers\" + 0.027*\"squibb\" + 0.025*\"humira\" + 0.019*\"bmy\" + 0.012*\"arthritis\" + 0.011*\"abbvie\" + 0.010*\"ibrutinib\" + 0.009*\"rheumatoid\" + 0.008*\"adalimumab\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.029*\"abbvie\" + 0.028*\"humira\" + 0.027*\"arthritis\" + 0.024*\"rheumatoid\" + 0.015*\"inc\" + 0.014*\"abbv\" + 0.011*\"psoriasis\" + 0.009*\"biosimilar\" + 0.009*\"adalimumab\" + 0.008*\"hcv\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.020*\"bristol\" + 0.020*\"myers\" + 0.017*\"hcv\" + 0.017*\"cancer\" + 0.016*\"adalimumab\" + 0.014*\"squibb\" + 0.013*\"humira\" + 0.012*\"psoriasis\" + 0.010*\"arthritis\" + 0.010*\"new\"\n",
      "INFO:gensim.models.ldamodel:topic #7 (0.033): 0.035*\"humira\" + 0.034*\"psoriasis\" + 0.034*\"abbvie\" + 0.018*\"inc\" + 0.015*\"abbv\" + 0.012*\"adalimumab\" + 0.008*\"hold\" + 0.007*\"amgen\" + 0.007*\"via\" + 0.007*\"cost\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.054*\"abbvie\" + 0.035*\"bristol\" + 0.030*\"myers\" + 0.027*\"inc\" + 0.024*\"abbv\" + 0.021*\"squibb\" + 0.013*\"bmy\" + 0.011*\"new\" + 0.011*\"psoriasis\" + 0.009*\"arthritis\"\n",
      "INFO:gensim.models.ldamodel:topic diff=1.044063, rho=0.332448\n",
      "INFO:gensim.models.ldamodel:-7.913 per-word bound, 241.0 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 1, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.058*\"abbvie\" + 0.044*\"inc\" + 0.041*\"bristol\" + 0.036*\"myers\" + 0.032*\"abbv\" + 0.027*\"squibb\" + 0.022*\"bmy\" + 0.011*\"new\" + 0.010*\"shares\" + 0.010*\"amgen\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.047*\"abbvie\" + 0.028*\"humira\" + 0.020*\"abbv\" + 0.012*\"ibrutinib\" + 0.011*\"price\" + 0.011*\"hcv\" + 0.011*\"cll\" + 0.009*\"continues\" + 0.009*\"inc\" + 0.008*\"adalimumab\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.026*\"humira\" + 0.024*\"abbvie\" + 0.017*\"enbrel\" + 0.016*\"biosimilar\" + 0.014*\"efficacy\" + 0.013*\"new\" + 0.011*\"abbv\" + 0.011*\"squibb\" + 0.011*\"equivalent\" + 0.011*\"sandoz\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.038*\"abbvie\" + 0.029*\"humira\" + 0.014*\"enbrel\" + 0.013*\"like\" + 0.011*\"imbruvica\" + 0.010*\"myers\" + 0.010*\"bristol\" + 0.010*\"drug\" + 0.009*\"i'm\" + 0.009*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.021*\"abbvie\" + 0.020*\"arthritis\" + 0.016*\"new\" + 0.014*\"ibrutinib\" + 0.014*\"rheumatoid\" + 0.012*\"amgen\" + 0.011*\"partner\" + 0.011*\"bristol\" + 0.010*\"cancer\" + 0.010*\"myers\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.268827, rho=0.300856\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.053*\"psoriasis\" + 0.028*\"skin\" + 0.015*\"acne\" + 0.014*\"eczema\" + 0.013*\"humira\" + 0.011*\"new\" + 0.011*\"arthritis\" + 0.011*\"rheumatoid\" + 0.011*\"soap\" + 0.011*\"care\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.035*\"bristol\" + 0.030*\"myers\" + 0.027*\"squibb\" + 0.019*\"psoriasis\" + 0.011*\"humira\" + 0.011*\"arthritis\" + 0.010*\"merck\" + 0.010*\"read\" + 0.010*\"avillion\" + 0.010*\"director\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.029*\"arthritis\" + 0.026*\"new\" + 0.021*\"rheumatoid\" + 0.018*\"abbvie\" + 0.016*\"amgen\" + 0.015*\"cancer\" + 0.011*\"ibrutinib\" + 0.011*\"research\" + 0.011*\"treatment\" + 0.010*\"data\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.076*\"bristol\" + 0.073*\"myers\" + 0.070*\"squibb\" + 0.023*\"bmy\" + 0.022*\"oncology\" + 0.019*\"network\" + 0.019*\"international\" + 0.019*\"expands\" + 0.019*\"immuno\" + 0.013*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.038*\"arthritis\" + 0.036*\"rheumatoid\" + 0.034*\"humira\" + 0.020*\"abbvie\" + 0.017*\"biosimilar\" + 0.013*\"approved\" + 0.013*\"approval\" + 0.013*\"psoriasis\" + 0.011*\"europe\" + 0.010*\"linked\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.312154, rho=0.300856\n",
      "INFO:gensim.models.ldamodel:merging changes from 1048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.097*\"arthritis\" + 0.088*\"rheumatoid\" + 0.014*\"therapy\" + 0.011*\"new\" + 0.011*\"amgen\" + 0.009*\"prognosis\" + 0.009*\"abbvie\" + 0.008*\"tool\" + 0.008*\"choice\" + 0.008*\"inflammation\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.042*\"psoriasis\" + 0.022*\"skin\" + 0.013*\"humira\" + 0.012*\"abbvie\" + 0.011*\"adalimumab\" + 0.011*\"acne\" + 0.011*\"care\" + 0.011*\"eczema\" + 0.010*\"new\" + 0.010*\"show\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.038*\"bristol\" + 0.035*\"myers\" + 0.031*\"squibb\" + 0.020*\"director\" + 0.018*\"amgen\" + 0.016*\"jobs\" + 0.015*\"oaks\" + 0.012*\"psoriasis\" + 0.011*\"read\" + 0.011*\"via\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.054*\"humira\" + 0.053*\"abbvie\" + 0.030*\"abbv\" + 0.029*\"court\" + 0.027*\"patents\" + 0.023*\"amgen\" + 0.020*\"good\" + 0.018*\"biosimilars\" + 0.016*\"invalidates\" + 0.015*\"inc\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.038*\"amgen\" + 0.034*\"bristol\" + 0.032*\"myers\" + 0.026*\"squibb\" + 0.025*\"jobs\" + 0.021*\"read\" + 0.021*\"oaks\" + 0.018*\"bmy\" + 0.018*\"manager\" + 0.018*\"marketing\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.339688, rho=0.300856\n",
      "INFO:gensim.models.ldamodel:-7.057 per-word bound, 133.1 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 2, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.061*\"arthritis\" + 0.054*\"rheumatoid\" + 0.016*\"abbvie\" + 0.014*\"pain\" + 0.013*\"drug\" + 0.012*\"psoriasis\" + 0.012*\"new\" + 0.012*\"ibrutinib\" + 0.010*\"could\" + 0.010*\"symptoms\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.044*\"abbvie\" + 0.020*\"squibb\" + 0.019*\"collaboration\" + 0.018*\"clinical\" + 0.014*\"myers\" + 0.014*\"bristol\" + 0.013*\"new\" + 0.010*\"humira\" + 0.010*\"trial\" + 0.009*\"hcv\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.103*\"bristol\" + 0.099*\"myers\" + 0.090*\"squibb\" + 0.031*\"bmy\" + 0.021*\"oncology\" + 0.020*\"new\" + 0.020*\"network\" + 0.019*\"international\" + 0.019*\"expands\" + 0.019*\"company\"\n",
      "INFO:gensim.models.ldamodel:topic #0 (0.033): 0.079*\"abbvie\" + 0.036*\"abbv\" + 0.028*\"inc\" + 0.021*\"position\" + 0.019*\"positive\" + 0.019*\"opinion\" + 0.018*\"chmp\" + 0.017*\"receives\" + 0.016*\"treatment\" + 0.014*\"week\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.029*\"hcv\" + 0.019*\"cancer\" + 0.019*\"adalimumab\" + 0.014*\"chronic\" + 0.012*\"arthritis\" + 0.012*\"psoriasis\" + 0.011*\"rheumatoid\" + 0.010*\"patients\" + 0.010*\"bristol\" + 0.010*\"inflammatory\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.330128, rho=0.288100\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #0 (0.033): 0.079*\"abbvie\" + 0.035*\"abbv\" + 0.027*\"inc\" + 0.021*\"position\" + 0.016*\"positive\" + 0.016*\"opinion\" + 0.015*\"chmp\" + 0.014*\"treatment\" + 0.014*\"receives\" + 0.012*\"week\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.059*\"abbvie\" + 0.043*\"humira\" + 0.019*\"abbv\" + 0.017*\"continues\" + 0.014*\"price\" + 0.014*\"attacked\" + 0.011*\"great\" + 0.010*\"research\" + 0.010*\"program\" + 0.010*\"enbrel\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.021*\"humira\" + 0.018*\"reynolds\" + 0.018*\"dan\" + 0.017*\"imagine\" + 0.017*\"health\" + 0.017*\"ankylosing\" + 0.016*\"spondylitis\" + 0.013*\"twitter\" + 0.012*\"abbvie\" + 0.011*\"woman\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.035*\"bristol\" + 0.032*\"myers\" + 0.030*\"squibb\" + 0.021*\"director\" + 0.019*\"psoriasis\" + 0.016*\"signs\" + 0.016*\"amgen\" + 0.014*\"medicine\" + 0.014*\"avillion\" + 0.013*\"merck\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.052*\"psoriasis\" + 0.040*\"arthritis\" + 0.035*\"rheumatoid\" + 0.013*\"humira\" + 0.012*\"people\" + 0.012*\"like\" + 0.012*\"thanks\" + 0.011*\"rheumatoidarthritis\" + 0.011*\"know\" + 0.009*\"disease\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.397424, rho=0.288100\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.024*\"new\" + 0.019*\"abbvie\" + 0.018*\"arthritis\" + 0.018*\"ibrutinib\" + 0.017*\"cancer\" + 0.017*\"partner\" + 0.016*\"amgen\" + 0.013*\"bms\" + 0.011*\"treatment\" + 0.011*\"project\"\n",
      "INFO:gensim.models.ldamodel:topic #6 (0.033): 0.039*\"study\" + 0.038*\"amgen's\" + 0.037*\"kyprolis\" + 0.036*\"myeloma\" + 0.035*\"velcade\" + 0.034*\"survival\" + 0.031*\"seen\" + 0.028*\"longer\" + 0.016*\"psoriasis\" + 0.014*\"hcv\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.095*\"inc\" + 0.083*\"abbvie\" + 0.055*\"abbv\" + 0.027*\"bristol\" + 0.025*\"myers\" + 0.025*\"shares\" + 0.022*\"stake\" + 0.021*\"bmy\" + 0.021*\"llc\" + 0.019*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.027*\"imagine\" + 0.026*\"reynolds\" + 0.026*\"dan\" + 0.021*\"health\" + 0.021*\"humira\" + 0.019*\"dragons\" + 0.017*\"high\" + 0.017*\"made\" + 0.017*\"believer\" + 0.017*\"issues\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.060*\"psoriasis\" + 0.034*\"skin\" + 0.017*\"eczema\" + 0.015*\"acne\" + 0.013*\"soap\" + 0.012*\"show\" + 0.012*\"abbvie\" + 0.012*\"adalimumab\" + 0.012*\"care\" + 0.011*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.445019, rho=0.288100\n",
      "INFO:gensim.models.ldamodel:-6.969 per-word bound, 125.3 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 3, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.070*\"arthritis\" + 0.061*\"rheumatoid\" + 0.022*\"pain\" + 0.017*\"drug\" + 0.014*\"could\" + 0.013*\"ibrutinib\" + 0.013*\"new\" + 0.013*\"learn\" + 0.012*\"symptoms\" + 0.012*\"abbvie\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.032*\"hcv\" + 0.019*\"cancer\" + 0.018*\"adalimumab\" + 0.017*\"anti\" + 0.017*\"chronic\" + 0.016*\"inflammatory\" + 0.016*\"arthritis\" + 0.015*\"rheumatoid\" + 0.014*\"fight\" + 0.013*\"flares\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.102*\"inc\" + 0.083*\"abbvie\" + 0.059*\"abbv\" + 0.025*\"bmy\" + 0.025*\"bristol\" + 0.025*\"shares\" + 0.023*\"myers\" + 0.022*\"stake\" + 0.020*\"llc\" + 0.018*\"capital\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.059*\"bristol\" + 0.057*\"myers\" + 0.040*\"squibb\" + 0.018*\"arthritis\" + 0.018*\"rheumatoid\" + 0.013*\"ibrutinib\" + 0.013*\"bmy\" + 0.010*\"time\" + 0.010*\"taking\" + 0.009*\"pain\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.035*\"humira\" + 0.032*\"arthritis\" + 0.028*\"rheumatoid\" + 0.016*\"biosimilar\" + 0.016*\"approved\" + 0.016*\"treatment\" + 0.015*\"approval\" + 0.015*\"abbvie\" + 0.013*\"europe\" + 0.013*\"linked\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.448949, rho=0.276839\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.069*\"humira\" + 0.056*\"psoriasis\" + 0.045*\"fda\" + 0.042*\"fingernail\" + 0.040*\"abbvie's\" + 0.037*\"approves\" + 0.037*\"severe\" + 0.034*\"data\" + 0.033*\"moderate\" + 0.028*\"addition\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.030*\"abbvie\" + 0.016*\"amgen\" + 0.016*\"top\" + 0.015*\"patients\" + 0.012*\"research\" + 0.012*\"doctors\" + 0.011*\"news\" + 0.011*\"relapsed\" + 0.010*\"bristol\" + 0.009*\"story\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.063*\"amgen\" + 0.036*\"jobs\" + 0.027*\"bristol\" + 0.026*\"myers\" + 0.026*\"manager\" + 0.023*\"marketing\" + 0.023*\"oaks\" + 0.022*\"read\" + 0.022*\"squibb\" + 0.017*\"abbvie\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.046*\"bristol\" + 0.044*\"myers\" + 0.032*\"squibb\" + 0.027*\"arthritis\" + 0.026*\"rheumatoid\" + 0.015*\"pain\" + 0.013*\"suffers\" + 0.011*\"chronic\" + 0.011*\"head\" + 0.010*\"gaga\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.021*\"imagine\" + 0.021*\"reynolds\" + 0.021*\"dan\" + 0.020*\"health\" + 0.019*\"humira\" + 0.017*\"ankylosing\" + 0.016*\"spondylitis\" + 0.014*\"dragons\" + 0.014*\"made\" + 0.013*\"high\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.521637, rho=0.276839\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.073*\"amgen\" + 0.054*\"jobs\" + 0.036*\"manager\" + 0.036*\"oaks\" + 0.035*\"marketing\" + 0.023*\"lgbtbizhub\" + 0.023*\"lgbtpro\" + 0.023*\"bristol\" + 0.022*\"myers\" + 0.020*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.140*\"bristol\" + 0.134*\"myers\" + 0.109*\"squibb\" + 0.039*\"new\" + 0.035*\"bmy\" + 0.025*\"chief\" + 0.021*\"takeover\" + 0.021*\"would\" + 0.021*\"company\" + 0.020*\"massive\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.029*\"imagine\" + 0.028*\"reynolds\" + 0.028*\"dan\" + 0.025*\"health\" + 0.021*\"made\" + 0.020*\"believer\" + 0.020*\"dragons\" + 0.019*\"high\" + 0.019*\"issues\" + 0.018*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.069*\"biosimilar\" + 0.058*\"adalimumab\" + 0.057*\"equivalent\" + 0.052*\"efficacy\" + 0.051*\"sandoz\" + 0.049*\"proposed\" + 0.047*\"data\" + 0.045*\"new\" + 0.040*\"demonstrate\" + 0.026*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.080*\"arthritis\" + 0.067*\"rheumatoid\" + 0.027*\"pain\" + 0.019*\"drug\" + 0.017*\"could\" + 0.015*\"new\" + 0.015*\"symptoms\" + 0.015*\"ibrutinib\" + 0.014*\"joint\" + 0.012*\"learn\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.552167, rho=0.276839\n",
      "INFO:gensim.models.ldamodel:-6.868 per-word bound, 116.8 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 4, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.069*\"abbvie\" + 0.067*\"humira\" + 0.029*\"continues\" + 0.025*\"attacked\" + 0.025*\"abbv\" + 0.021*\"price\" + 0.013*\"last\" + 0.013*\"per\" + 0.012*\"month\" + 0.012*\"enbrel\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.138*\"bristol\" + 0.133*\"myers\" + 0.116*\"squibb\" + 0.043*\"bmy\" + 0.027*\"new\" + 0.023*\"company\" + 0.017*\"oncology\" + 0.017*\"bristolmyerssquibb\" + 0.016*\"network\" + 0.016*\"international\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.049*\"enbrel\" + 0.035*\"humira\" + 0.029*\"based\" + 0.024*\"arthritis\" + 0.021*\"rheumatoid\" + 0.020*\"amgen\" + 0.017*\"value\" + 0.016*\"ibrutinib\" + 0.014*\"deal\" + 0.012*\"signs\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.048*\"study\" + 0.041*\"phase\" + 0.035*\"positive\" + 0.030*\"data\" + 0.026*\"tgtx\" + 0.023*\"topline\" + 0.021*\"combination\" + 0.021*\"genuine\" + 0.021*\"ibrutinib\" + 0.020*\"announces\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.064*\"psoriasis\" + 0.036*\"skin\" + 0.019*\"eczema\" + 0.016*\"acne\" + 0.015*\"show\" + 0.015*\"care\" + 0.014*\"humira\" + 0.013*\"adalimumab\" + 0.013*\"soap\" + 0.012*\"phase\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.535704, rho=0.266804\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.067*\"abbvie\" + 0.062*\"humira\" + 0.024*\"continues\" + 0.021*\"abbv\" + 0.021*\"attacked\" + 0.018*\"price\" + 0.014*\"last\" + 0.013*\"didn't\" + 0.012*\"per\" + 0.012*\"month\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.058*\"abbvie\" + 0.057*\"humira\" + 0.039*\"good\" + 0.033*\"court\" + 0.029*\"abbv\" + 0.028*\"amgen\" + 0.027*\"patents\" + 0.026*\"biosimilars\" + 0.021*\"company\" + 0.020*\"market\"\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.171*\"arthritis\" + 0.157*\"rheumatoid\" + 0.015*\"new\" + 0.014*\"therapy\" + 0.013*\"disease\" + 0.012*\"diet\" + 0.012*\"autoimmune\" + 0.011*\"inflammation\" + 0.011*\"help\" + 0.009*\"prognosis\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.042*\"study\" + 0.037*\"phase\" + 0.029*\"positive\" + 0.026*\"data\" + 0.024*\"biosimilar\" + 0.021*\"tgtx\" + 0.020*\"adalimumab\" + 0.019*\"treatment\" + 0.018*\"topline\" + 0.017*\"ibrutinib\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.045*\"arthritis\" + 0.042*\"rheumatoid\" + 0.039*\"humira\" + 0.027*\"biosimilar\" + 0.027*\"approved\" + 0.022*\"best\" + 0.022*\"approval\" + 0.021*\"linked\" + 0.020*\"europe\" + 0.018*\"disease\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.573989, rho=0.266804\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.037*\"director\" + 0.032*\"bristol\" + 0.030*\"myers\" + 0.028*\"squibb\" + 0.021*\"development\" + 0.017*\"read\" + 0.016*\"consumer\" + 0.016*\"amgen\" + 0.016*\"signs\" + 0.016*\"blog\"\n",
      "INFO:gensim.models.ldamodel:topic #6 (0.033): 0.047*\"study\" + 0.046*\"amgen's\" + 0.042*\"myeloma\" + 0.042*\"kyprolis\" + 0.041*\"survival\" + 0.041*\"seen\" + 0.040*\"velcade\" + 0.032*\"longer\" + 0.017*\"hcv\" + 0.014*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.087*\"amgen\" + 0.062*\"jobs\" + 0.040*\"oaks\" + 0.040*\"manager\" + 0.039*\"marketing\" + 0.026*\"lgbtbizhub\" + 0.026*\"lgbtpro\" + 0.022*\"global\" + 0.022*\"senior\" + 0.021*\"sales\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.039*\"bristol\" + 0.035*\"myers\" + 0.030*\"squibb\" + 0.029*\"bmy\" + 0.023*\"read\" + 0.019*\"opdivo\" + 0.018*\"bristolmyerssquibb\" + 0.017*\"shares\" + 0.016*\"cancer\" + 0.015*\"receives\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.082*\"spondylitis\" + 0.082*\"ankylosing\" + 0.032*\"hepatitis\" + 0.028*\"hcv\" + 0.019*\"use\" + 0.017*\"humira\" + 0.016*\"i'm\" + 0.014*\"treatment\" + 0.013*\"it's\" + 0.012*\"patients\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.564253, rho=0.266804\n",
      "INFO:gensim.models.ldamodel:-6.809 per-word bound, 112.2 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 5, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.048*\"bristol\" + 0.044*\"myers\" + 0.023*\"squibb\" + 0.022*\"time\" + 0.017*\"ibrutinib\" + 0.016*\"insider\" + 0.015*\"usa\" + 0.014*\"taking\" + 0.013*\"head\" + 0.013*\"arthritis\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.087*\"amgen\" + 0.058*\"jobs\" + 0.036*\"marketing\" + 0.036*\"manager\" + 0.036*\"oaks\" + 0.023*\"global\" + 0.021*\"lgbtbizhub\" + 0.021*\"lgbtpro\" + 0.020*\"read\" + 0.019*\"senior\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.087*\"spondylitis\" + 0.087*\"ankylosing\" + 0.038*\"hepatitis\" + 0.030*\"hcv\" + 0.020*\"use\" + 0.019*\"humira\" + 0.016*\"i'm\" + 0.014*\"it's\" + 0.013*\"treatment\" + 0.011*\"diagnosed\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.053*\"enbrel\" + 0.035*\"humira\" + 0.032*\"based\" + 0.024*\"arthritis\" + 0.020*\"rheumatoid\" + 0.020*\"amgen\" + 0.018*\"value\" + 0.014*\"deal\" + 0.013*\"remicade\" + 0.012*\"signs\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.059*\"bristol\" + 0.055*\"myers\" + 0.048*\"squibb\" + 0.044*\"bmy\" + 0.029*\"bristolmyerssquibb\" + 0.027*\"read\" + 0.019*\"appoints\" + 0.019*\"executive\" + 0.019*\"lynch\" + 0.019*\"high\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.513094, rho=0.257787\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.093*\"amgen\" + 0.053*\"jobs\" + 0.034*\"manager\" + 0.032*\"marketing\" + 0.031*\"oaks\" + 0.023*\"global\" + 0.020*\"read\" + 0.019*\"amgn\" + 0.019*\"abbvie\" + 0.018*\"lgbtbizhub\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.032*\"abbvie\" + 0.024*\"top\" + 0.020*\"patients\" + 0.017*\"amgen\" + 0.017*\"story\" + 0.015*\"doctors\" + 0.015*\"news\" + 0.014*\"research\" + 0.013*\"relapsed\" + 0.011*\"awareness\"\n",
      "INFO:gensim.models.ldamodel:topic #22 (0.033): 0.050*\"hcv\" + 0.035*\"abbvie\" + 0.019*\"twitter\" + 0.016*\"cancer\" + 0.016*\"liver\" + 0.016*\"via\" + 0.015*\"humira\" + 0.015*\"psoriasis\" + 0.013*\"href\" + 0.013*\"rel\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.027*\"new\" + 0.023*\"partner\" + 0.021*\"cancer\" + 0.021*\"ibrutinib\" + 0.018*\"meeting\" + 0.018*\"amgen\" + 0.016*\"annual\" + 0.016*\"bms\" + 0.015*\"american\" + 0.014*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.037*\"abbvie\" + 0.037*\"imbruvica\" + 0.027*\"humira\" + 0.024*\"like\" + 0.024*\"sales\" + 0.022*\"tgtx\" + 0.018*\"therapy\" + 0.017*\"combo\" + 0.016*\"don't\" + 0.015*\"bad\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.519904, rho=0.257787\n",
      "INFO:gensim.models.ldamodel:merging changes from 1048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.034*\"anti\" + 0.029*\"hcv\" + 0.029*\"inflammatory\" + 0.026*\"arthritis\" + 0.025*\"rheumatoid\" + 0.023*\"fight\" + 0.023*\"flares\" + 0.023*\"fatigue\" + 0.023*\"cancer\" + 0.022*\"cookbook\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.067*\"psoriasis\" + 0.023*\"arthritis\" + 0.019*\"today\" + 0.018*\"thanks\" + 0.017*\"rheumatoid\" + 0.016*\"humira\" + 0.016*\"like\" + 0.015*\"people\" + 0.012*\"rheumatoidarthritis\" + 0.012*\"may\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.057*\"bristol\" + 0.054*\"myers\" + 0.050*\"squibb\" + 0.039*\"bmy\" + 0.026*\"executive\" + 0.026*\"appoints\" + 0.026*\"vice\" + 0.026*\"bristolmyerssquibb\" + 0.025*\"lynch\" + 0.025*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.079*\"abbvie\" + 0.076*\"humira\" + 0.037*\"continues\" + 0.035*\"attacked\" + 0.029*\"abbv\" + 0.019*\"price\" + 0.014*\"per\" + 0.012*\"last\" + 0.011*\"month\" + 0.011*\"enbrel\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.136*\"inc\" + 0.103*\"abbvie\" + 0.079*\"abbv\" + 0.035*\"shares\" + 0.026*\"stake\" + 0.026*\"llc\" + 0.025*\"management\" + 0.021*\"capital\" + 0.016*\"position\" + 0.014*\"bmy\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.480328, rho=0.257787\n",
      "INFO:gensim.models.ldamodel:-6.531 per-word bound, 92.5 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 6, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.039*\"humira\" + 0.035*\"arthritis\" + 0.031*\"rheumatoid\" + 0.024*\"best\" + 0.022*\"approved\" + 0.021*\"biosimilar\" + 0.019*\"approval\" + 0.018*\"linked\" + 0.017*\"europe\" + 0.017*\"gets\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.134*\"inc\" + 0.100*\"abbvie\" + 0.079*\"abbv\" + 0.033*\"shares\" + 0.025*\"stake\" + 0.025*\"management\" + 0.024*\"llc\" + 0.021*\"capital\" + 0.017*\"position\" + 0.017*\"vetr\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.052*\"study\" + 0.043*\"phase\" + 0.036*\"positive\" + 0.033*\"data\" + 0.030*\"tgtx\" + 0.029*\"ibrutinib\" + 0.024*\"combination\" + 0.023*\"topline\" + 0.022*\"genuine\" + 0.019*\"announces\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.065*\"humira\" + 0.059*\"abbvie\" + 0.045*\"court\" + 0.037*\"good\" + 0.036*\"patents\" + 0.030*\"abbv\" + 0.030*\"biosimilars\" + 0.029*\"amgen\" + 0.024*\"market\" + 0.019*\"company\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.028*\"ibrutinib\" + 0.026*\"partner\" + 0.020*\"new\" + 0.020*\"bms\" + 0.018*\"cancer\" + 0.017*\"project\" + 0.015*\"abbvie\" + 0.015*\"treatment\" + 0.014*\"hcv\" + 0.014*\"meeting\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.418444, rho=0.249626\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #0 (0.033): 0.066*\"abbvie\" + 0.032*\"opinion\" + 0.029*\"positive\" + 0.028*\"chmp\" + 0.028*\"treatment\" + 0.022*\"ibrutinib\" + 0.021*\"option\" + 0.021*\"combo\" + 0.021*\"receives\" + 0.020*\"week\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.048*\"enbrel\" + 0.034*\"arthritis\" + 0.031*\"humira\" + 0.030*\"rheumatoid\" + 0.028*\"based\" + 0.024*\"fibromyalgia\" + 0.021*\"tea\" + 0.021*\"heals\" + 0.019*\"multiple\" + 0.017*\"sclerosis\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.041*\"imbruvica\" + 0.035*\"abbvie\" + 0.027*\"sales\" + 0.026*\"humira\" + 0.025*\"tgtx\" + 0.025*\"like\" + 0.020*\"therapy\" + 0.018*\"combo\" + 0.018*\"don't\" + 0.015*\"bad\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.058*\"bristol\" + 0.054*\"myers\" + 0.046*\"squibb\" + 0.042*\"bmy\" + 0.028*\"bristolmyerssquibb\" + 0.026*\"read\" + 0.018*\"lynch\" + 0.018*\"executive\" + 0.018*\"appoints\" + 0.018*\"high\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.037*\"anti\" + 0.031*\"inflammatory\" + 0.029*\"arthritis\" + 0.029*\"rheumatoid\" + 0.028*\"hcv\" + 0.027*\"fight\" + 0.026*\"fatigue\" + 0.026*\"flares\" + 0.025*\"cookbook\" + 0.024*\"recipes\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.412979, rho=0.249626\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.164*\"bristol\" + 0.159*\"myers\" + 0.130*\"squibb\" + 0.050*\"bmy\" + 0.037*\"new\" + 0.024*\"chief\" + 0.024*\"company\" + 0.018*\"takeover\" + 0.018*\"would\" + 0.017*\"massive\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.049*\"enbrel\" + 0.033*\"humira\" + 0.031*\"arthritis\" + 0.027*\"based\" + 0.025*\"rheumatoid\" + 0.019*\"fibromyalgia\" + 0.017*\"tea\" + 0.016*\"heals\" + 0.015*\"multiple\" + 0.014*\"amgen\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.106*\"amgen\" + 0.071*\"jobs\" + 0.046*\"oaks\" + 0.043*\"marketing\" + 0.043*\"manager\" + 0.028*\"lgbtbizhub\" + 0.028*\"lgbtpro\" + 0.026*\"global\" + 0.023*\"senior\" + 0.020*\"sales\"\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.047*\"psoriasis\" + 0.046*\"ibrutinib\" + 0.026*\"abbv\" + 0.024*\"chronic\" + 0.023*\"plaque\" + 0.020*\"lymphocytic\" + 0.020*\"abbvie\" + 0.020*\"symptoms\" + 0.018*\"tgtx\" + 0.017*\"leukemia\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.038*\"bristol\" + 0.034*\"myers\" + 0.030*\"squibb\" + 0.029*\"bmy\" + 0.027*\"read\" + 0.020*\"opdivo\" + 0.019*\"bristolmyerssquibb\" + 0.018*\"cancer\" + 0.018*\"shares\" + 0.016*\"receives\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.372000, rho=0.249626\n",
      "INFO:gensim.models.ldamodel:-6.576 per-word bound, 95.4 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 7, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.038*\"director\" + 0.025*\"investment\" + 0.024*\"squibb\" + 0.024*\"focus\" + 0.024*\"bristol\" + 0.024*\"medicine\" + 0.023*\"myers\" + 0.022*\"precision\" + 0.021*\"blog\" + 0.021*\"development\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.059*\"psoriasis\" + 0.022*\"today\" + 0.021*\"thanks\" + 0.020*\"humira\" + 0.018*\"like\" + 0.016*\"people\" + 0.015*\"arthritis\" + 0.013*\"day\" + 0.012*\"cause\" + 0.012*\"may\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.028*\"ibrutinib\" + 0.026*\"partner\" + 0.020*\"new\" + 0.020*\"bms\" + 0.018*\"cancer\" + 0.017*\"project\" + 0.015*\"treatment\" + 0.015*\"abbvie\" + 0.014*\"hcv\" + 0.014*\"meeting\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.064*\"humira\" + 0.058*\"abbvie\" + 0.044*\"court\" + 0.038*\"good\" + 0.034*\"patents\" + 0.031*\"abbv\" + 0.031*\"biosimilars\" + 0.029*\"amgen\" + 0.025*\"market\" + 0.020*\"company\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.036*\"abbvie\" + 0.030*\"top\" + 0.020*\"patients\" + 0.018*\"amgen\" + 0.017*\"story\" + 0.016*\"share\" + 0.016*\"relapsed\" + 0.016*\"news\" + 0.014*\"research\" + 0.012*\"doctors\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.314777, rho=0.242194\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.033*\"director\" + 0.024*\"signs\" + 0.024*\"development\" + 0.023*\"psoriasis\" + 0.022*\"blog\" + 0.021*\"medicine\" + 0.020*\"focus\" + 0.020*\"merck\" + 0.020*\"investment\" + 0.020*\"squibb\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.037*\"anti\" + 0.031*\"inflammatory\" + 0.029*\"arthritis\" + 0.028*\"hcv\" + 0.028*\"rheumatoid\" + 0.027*\"fight\" + 0.026*\"fatigue\" + 0.026*\"flares\" + 0.025*\"cookbook\" + 0.024*\"recipes\"\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.074*\"humira\" + 0.063*\"psoriasis\" + 0.053*\"fda\" + 0.047*\"abbvie's\" + 0.046*\"severe\" + 0.045*\"fingernail\" + 0.041*\"moderate\" + 0.040*\"approves\" + 0.036*\"data\" + 0.030*\"addition\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.111*\"amgen\" + 0.060*\"jobs\" + 0.036*\"marketing\" + 0.036*\"manager\" + 0.035*\"oaks\" + 0.026*\"global\" + 0.022*\"amgn\" + 0.020*\"lgbtbizhub\" + 0.020*\"lgbtpro\" + 0.019*\"senior\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.044*\"arthritis\" + 0.041*\"humira\" + 0.040*\"rheumatoid\" + 0.029*\"biosimilar\" + 0.029*\"best\" + 0.029*\"approved\" + 0.023*\"approval\" + 0.023*\"linked\" + 0.022*\"disease\" + 0.022*\"europe\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.314010, rho=0.242194\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.085*\"biosimilar\" + 0.073*\"adalimumab\" + 0.061*\"equivalent\" + 0.059*\"efficacy\" + 0.056*\"sandoz\" + 0.054*\"data\" + 0.053*\"proposed\" + 0.050*\"new\" + 0.042*\"demonstrate\" + 0.026*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.113*\"amgen\" + 0.073*\"jobs\" + 0.048*\"oaks\" + 0.044*\"marketing\" + 0.043*\"manager\" + 0.029*\"lgbtbizhub\" + 0.029*\"lgbtpro\" + 0.027*\"global\" + 0.024*\"senior\" + 0.020*\"sales\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.051*\"abbvie\" + 0.029*\"collaboration\" + 0.027*\"clinical\" + 0.018*\"new\" + 0.017*\"research\" + 0.015*\"announce\" + 0.015*\"patient\" + 0.013*\"hcv\" + 0.013*\"trial\" + 0.012*\"healthcare\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.041*\"director\" + 0.025*\"development\" + 0.021*\"read\" + 0.021*\"blog\" + 0.019*\"need\" + 0.019*\"signs\" + 0.018*\"bristol\" + 0.018*\"squibb\" + 0.018*\"myers\" + 0.018*\"medicine\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.142*\"inc\" + 0.107*\"abbvie\" + 0.084*\"abbv\" + 0.037*\"shares\" + 0.028*\"management\" + 0.028*\"llc\" + 0.026*\"stake\" + 0.023*\"position\" + 0.021*\"capital\" + 0.013*\"vetr\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.278121, rho=0.242194\n",
      "INFO:gensim.models.ldamodel:-6.594 per-word bound, 96.6 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 8, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.103*\"spondylitis\" + 0.102*\"ankylosing\" + 0.044*\"hepatitis\" + 0.026*\"hcv\" + 0.022*\"i'm\" + 0.020*\"it's\" + 0.019*\"use\" + 0.017*\"humira\" + 0.014*\"diagnosed\" + 0.011*\"needs\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.033*\"health\" + 0.032*\"imagine\" + 0.028*\"reynolds\" + 0.028*\"dan\" + 0.027*\"made\" + 0.022*\"dragons\" + 0.021*\"issues\" + 0.021*\"believer\" + 0.020*\"life\" + 0.018*\"high\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.054*\"study\" + 0.044*\"phase\" + 0.037*\"positive\" + 0.035*\"data\" + 0.031*\"tgtx\" + 0.031*\"ibrutinib\" + 0.025*\"combination\" + 0.023*\"topline\" + 0.022*\"genuine\" + 0.020*\"announces\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.113*\"amgen\" + 0.067*\"jobs\" + 0.042*\"oaks\" + 0.041*\"marketing\" + 0.039*\"manager\" + 0.028*\"global\" + 0.024*\"lgbtbizhub\" + 0.024*\"lgbtpro\" + 0.021*\"senior\" + 0.020*\"amgn\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.041*\"bristol\" + 0.036*\"myers\" + 0.029*\"read\" + 0.028*\"bmy\" + 0.026*\"cancer\" + 0.024*\"squibb\" + 0.022*\"shares\" + 0.020*\"trials\" + 0.019*\"bristolmyerssquibb\" + 0.019*\"exelixis\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.232716, rho=0.235389\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.117*\"amgen\" + 0.062*\"jobs\" + 0.037*\"marketing\" + 0.037*\"oaks\" + 0.036*\"manager\" + 0.027*\"global\" + 0.023*\"amgn\" + 0.021*\"lgbtbizhub\" + 0.021*\"lgbtpro\" + 0.020*\"senior\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.056*\"enbrel\" + 0.033*\"humira\" + 0.032*\"arthritis\" + 0.029*\"based\" + 0.028*\"rheumatoid\" + 0.024*\"fibromyalgia\" + 0.021*\"tea\" + 0.021*\"heals\" + 0.020*\"multiple\" + 0.017*\"sclerosis\"\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.082*\"arthritis\" + 0.070*\"rheumatoid\" + 0.051*\"pain\" + 0.029*\"could\" + 0.023*\"drug\" + 0.023*\"joint\" + 0.021*\"symptoms\" + 0.019*\"new\" + 0.016*\"swelling\" + 0.015*\"learn\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.048*\"study\" + 0.040*\"phase\" + 0.032*\"positive\" + 0.031*\"data\" + 0.027*\"ibrutinib\" + 0.026*\"tgtx\" + 0.023*\"biosimilar\" + 0.020*\"combination\" + 0.020*\"adalimumab\" + 0.019*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.057*\"bristol\" + 0.053*\"myers\" + 0.045*\"squibb\" + 0.042*\"bmy\" + 0.029*\"bristolmyerssquibb\" + 0.027*\"read\" + 0.020*\"lynch\" + 0.020*\"executive\" + 0.020*\"appoints\" + 0.019*\"vice\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.240162, rho=0.235389\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.041*\"humira\" + 0.040*\"arthritis\" + 0.034*\"rheumatoid\" + 0.026*\"best\" + 0.025*\"biosimilar\" + 0.025*\"approved\" + 0.022*\"approval\" + 0.021*\"disease\" + 0.020*\"linked\" + 0.019*\"europe\"\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.074*\"humira\" + 0.056*\"psoriasis\" + 0.051*\"abbvie's\" + 0.048*\"fda\" + 0.040*\"severe\" + 0.038*\"fingernail\" + 0.037*\"moderate\" + 0.035*\"approves\" + 0.030*\"data\" + 0.025*\"addition\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.058*\"enbrel\" + 0.034*\"humira\" + 0.030*\"arthritis\" + 0.027*\"based\" + 0.024*\"rheumatoid\" + 0.019*\"fibromyalgia\" + 0.017*\"tea\" + 0.016*\"heals\" + 0.016*\"multiple\" + 0.015*\"amgen\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.056*\"bristol\" + 0.053*\"myers\" + 0.050*\"squibb\" + 0.039*\"bmy\" + 0.028*\"executive\" + 0.028*\"appoints\" + 0.028*\"vice\" + 0.028*\"lynch\" + 0.027*\"bristolmyerssquibb\" + 0.026*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.060*\"imbruvica\" + 0.039*\"tgtx\" + 0.035*\"sales\" + 0.033*\"abbvie\" + 0.027*\"therapy\" + 0.026*\"combo\" + 0.019*\"humira\" + 0.019*\"like\" + 0.018*\"don't\" + 0.018*\"new\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.212190, rho=0.235389\n",
      "INFO:gensim.models.ldamodel:-6.595 per-word bound, 96.7 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #0 = documents up to #1000/9048, outstanding queue size 1\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #1 = documents up to #2000/9048, outstanding queue size 2\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #2 = documents up to #3000/9048, outstanding queue size 3\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #3 = documents up to #4000/9048, outstanding queue size 4\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #4 = documents up to #5000/9048, outstanding queue size 5\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #5 = documents up to #6000/9048, outstanding queue size 6\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #6 = documents up to #7000/9048, outstanding queue size 7\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #7 = documents up to #8000/9048, outstanding queue size 8\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #8 = documents up to #9000/9048, outstanding queue size 9\n",
      "INFO:gensim.models.ldamulticore:PROGRESS: pass 9, dispatched chunk #9 = documents up to #9048/9048, outstanding queue size 10\n",
      "INFO:gensim.models.ldamodel:merging changes from 4000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.105*\"spondylitis\" + 0.103*\"ankylosing\" + 0.044*\"hepatitis\" + 0.026*\"hcv\" + 0.022*\"i'm\" + 0.021*\"it's\" + 0.019*\"use\" + 0.017*\"humira\" + 0.014*\"diagnosed\" + 0.011*\"abbvie\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.055*\"abbvie\" + 0.031*\"collaboration\" + 0.030*\"clinical\" + 0.016*\"new\" + 0.016*\"exelixis\" + 0.015*\"patient\" + 0.014*\"trial\" + 0.013*\"research\" + 0.013*\"healthcare\" + 0.013*\"hcv\"\n",
      "INFO:gensim.models.ldamodel:topic #22 (0.033): 0.063*\"hcv\" + 0.042*\"abbvie\" + 0.021*\"twitter\" + 0.017*\"liver\" + 0.017*\"humira\" + 0.016*\"cancer\" + 0.016*\"hiv\" + 0.015*\"via\" + 0.014*\"href\" + 0.014*\"rel\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.039*\"hcv\" + 0.029*\"anti\" + 0.023*\"inflammatory\" + 0.023*\"review\" + 0.021*\"chronic\" + 0.020*\"arthritis\" + 0.020*\"cancer\" + 0.020*\"fight\" + 0.019*\"rheumatoid\" + 0.019*\"fatigue\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.054*\"study\" + 0.044*\"phase\" + 0.037*\"positive\" + 0.036*\"data\" + 0.032*\"ibrutinib\" + 0.031*\"tgtx\" + 0.025*\"combination\" + 0.024*\"topline\" + 0.023*\"genuine\" + 0.020*\"announces\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.176923, rho=0.229126\n",
      "INFO:gensim.models.ldamodel:merging changes from 4048 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.038*\"anti\" + 0.031*\"inflammatory\" + 0.030*\"hcv\" + 0.028*\"arthritis\" + 0.027*\"fight\" + 0.027*\"rheumatoid\" + 0.026*\"fatigue\" + 0.026*\"flares\" + 0.025*\"cookbook\" + 0.024*\"recipes\"\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.197*\"arthritis\" + 0.176*\"rheumatoid\" + 0.015*\"new\" + 0.015*\"disease\" + 0.013*\"help\" + 0.013*\"therapy\" + 0.011*\"diet\" + 0.011*\"autoimmune\" + 0.010*\"inflammation\" + 0.009*\"patients\"\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.051*\"ibrutinib\" + 0.048*\"psoriasis\" + 0.025*\"chronic\" + 0.023*\"plaque\" + 0.022*\"lymphocytic\" + 0.019*\"leukemia\" + 0.018*\"cll\" + 0.018*\"symptoms\" + 0.017*\"drug\" + 0.017*\"abbv\"\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.073*\"humira\" + 0.064*\"psoriasis\" + 0.053*\"fda\" + 0.049*\"abbvie's\" + 0.047*\"severe\" + 0.046*\"fingernail\" + 0.042*\"moderate\" + 0.041*\"approves\" + 0.037*\"data\" + 0.030*\"addition\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.037*\"abbvie\" + 0.029*\"top\" + 0.025*\"patients\" + 0.022*\"share\" + 0.018*\"story\" + 0.018*\"amgen\" + 0.015*\"news\" + 0.014*\"doctors\" + 0.013*\"research\" + 0.013*\"awareness\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.193668, rho=0.229126\n",
      "INFO:gensim.models.ldamodel:merging changes from 1000 documents into a model of 9048 documents\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.191*\"arthritis\" + 0.169*\"rheumatoid\" + 0.014*\"disease\" + 0.014*\"new\" + 0.013*\"help\" + 0.013*\"therapy\" + 0.010*\"diet\" + 0.010*\"autoimmune\" + 0.010*\"inflammation\" + 0.009*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #7 (0.033): 0.071*\"humira\" + 0.030*\"abbvie\" + 0.027*\"psoriasis\" + 0.027*\"shows\" + 0.024*\"meets\" + 0.021*\"adalimumab\" + 0.020*\"research\" + 0.019*\"biosimilar\" + 0.018*\"efficacy\" + 0.018*\"cost\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.105*\"spondylitis\" + 0.104*\"ankylosing\" + 0.040*\"hepatitis\" + 0.024*\"hcv\" + 0.023*\"i'm\" + 0.022*\"it's\" + 0.019*\"use\" + 0.015*\"humira\" + 0.013*\"diagnosed\" + 0.013*\"woundgod\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.043*\"director\" + 0.026*\"development\" + 0.024*\"read\" + 0.023*\"blog\" + 0.021*\"need\" + 0.020*\"signs\" + 0.020*\"medicine\" + 0.018*\"focus\" + 0.018*\"investment\" + 0.018*\"psoriasis\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.052*\"abbvie\" + 0.030*\"collaboration\" + 0.027*\"clinical\" + 0.018*\"new\" + 0.017*\"research\" + 0.016*\"patient\" + 0.015*\"announce\" + 0.014*\"hcv\" + 0.012*\"information\" + 0.012*\"healthcare\"\n",
      "INFO:gensim.models.ldamodel:topic diff=0.171399, rho=0.229126\n",
      "INFO:gensim.models.ldamodel:-6.596 per-word bound, 96.7 perplexity estimate based on a held-out corpus of 48 documents with 353 words\n"
     ]
    }
   ],
   "source": [
    "corpus=list(df_postn['re_message'])\n",
    "#split=' '.join(re.findall(r\"[\\w']+\", doc)).lower().split()\n",
    "doc_cl = [doc.split() for doc in corpus]\n",
    "#print(doc_cl)\n",
    "dictionary = corpora.Dictionary(doc_cl)\n",
    "dictionary.filter_extremes(no_below=5, no_above=0.9)\n",
    "doc_term_matrix = [dictionary.doc2bow(doc) for doc in doc_cl]\n",
    "Ldamulticore=gensim.models.ldamulticore.LdaMulticore\n",
    "lda=Ldamulticore(doc_term_matrix, id2word=dictionary,num_topics=30, chunksize=1000, passes=10,workers=4)\n",
    "# Assign each document to most prevalent document\n",
    "lda_topic_assignment = [max(p,key=lambda item: item[1]) for p in lda[doc_term_matrix]]\n",
    "# Converting list of documents (corpus) into Document Term Matrix using dictionary prepared above."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO:gensim.models.ldamodel:topic #0 (0.033): 0.052*\"abbvie\" + 0.037*\"ibrutinib\" + 0.031*\"combo\" + 0.031*\"opinion\" + 0.031*\"cll\" + 0.028*\"phase\" + 0.027*\"treatment\" + 0.027*\"ublituximab\" + 0.027*\"chmp\" + 0.027*\"positive\"\n",
      "INFO:gensim.models.ldamodel:topic #1 (0.033): 0.087*\"humira\" + 0.082*\"abbvie\" + 0.037*\"continues\" + 0.035*\"attacked\" + 0.030*\"abbv\" + 0.019*\"price\" + 0.014*\"per\" + 0.013*\"i'm\" + 0.012*\"last\" + 0.012*\"enbrel\"\n",
      "INFO:gensim.models.ldamodel:topic #2 (0.033): 0.036*\"anti\" + 0.032*\"hcv\" + 0.029*\"inflammatory\" + 0.025*\"arthritis\" + 0.024*\"fight\" + 0.024*\"rheumatoid\" + 0.024*\"fatigue\" + 0.023*\"cancer\" + 0.023*\"flares\" + 0.022*\"cookbook\"\n",
      "INFO:gensim.models.ldamodel:topic #3 (0.033): 0.071*\"psoriasis\" + 0.030*\"like\" + 0.023*\"thanks\" + 0.020*\"today\" + 0.019*\"people\" + 0.016*\"humira\" + 0.014*\"find\" + 0.014*\"know\" + 0.014*\"day\" + 0.012*\"latest\"\n",
      "INFO:gensim.models.ldamodel:topic #4 (0.033): 0.040*\"abbvie\" + 0.027*\"top\" + 0.024*\"patients\" + 0.022*\"share\" + 0.019*\"story\" + 0.018*\"amgen\" + 0.016*\"news\" + 0.014*\"awareness\" + 0.014*\"hidradenitissuppurativa\" + 0.013*\"research\"\n",
      "INFO:gensim.models.ldamodel:topic #5 (0.033): 0.030*\"ibrutinib\" + 0.024*\"new\" + 0.023*\"partner\" + 0.020*\"cancer\" + 0.017*\"bms\" + 0.017*\"abbvie\" + 0.016*\"meeting\" + 0.016*\"amgen\" + 0.016*\"annual\" + 0.015*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #6 (0.033): 0.053*\"study\" + 0.050*\"amgen's\" + 0.045*\"seen\" + 0.045*\"myeloma\" + 0.045*\"survival\" + 0.044*\"kyprolis\" + 0.043*\"velcade\" + 0.035*\"longer\" + 0.017*\"hcv\" + 0.014*\"non\"\n",
      "INFO:gensim.models.ldamodel:topic #7 (0.033): 0.071*\"humira\" + 0.030*\"abbvie\" + 0.027*\"psoriasis\" + 0.027*\"shows\" + 0.024*\"meets\" + 0.021*\"adalimumab\" + 0.020*\"research\" + 0.019*\"biosimilar\" + 0.018*\"efficacy\" + 0.018*\"cost\"\n",
      "INFO:gensim.models.ldamodel:topic #8 (0.033): 0.052*\"abbvie\" + 0.030*\"collaboration\" + 0.027*\"clinical\" + 0.018*\"new\" + 0.017*\"research\" + 0.016*\"patient\" + 0.015*\"announce\" + 0.014*\"hcv\" + 0.012*\"information\" + 0.012*\"healthcare\"\n",
      "INFO:gensim.models.ldamodel:topic #9 (0.033): 0.121*\"amgen\" + 0.074*\"jobs\" + 0.049*\"oaks\" + 0.045*\"marketing\" + 0.044*\"manager\" + 0.029*\"lgbtbizhub\" + 0.029*\"lgbtpro\" + 0.028*\"global\" + 0.024*\"senior\" + 0.020*\"sales\"\n",
      "INFO:gensim.models.ldamodel:topic #10 (0.033): 0.061*\"enbrel\" + 0.035*\"humira\" + 0.029*\"arthritis\" + 0.027*\"based\" + 0.023*\"rheumatoid\" + 0.019*\"fibromyalgia\" + 0.017*\"tea\" + 0.016*\"heals\" + 0.016*\"multiple\" + 0.015*\"amgen\"\n",
      "INFO:gensim.models.ldamodel:topic #11 (0.033): 0.047*\"ibrutinib\" + 0.047*\"psoriasis\" + 0.025*\"chronic\" + 0.025*\"abbv\" + 0.023*\"plaque\" + 0.022*\"lymphocytic\" + 0.020*\"symptoms\" + 0.020*\"abbvie\" + 0.019*\"leukemia\" + 0.017*\"tgtx\"\n",
      "INFO:gensim.models.ldamodel:topic #12 (0.033): 0.041*\"humira\" + 0.040*\"arthritis\" + 0.034*\"rheumatoid\" + 0.027*\"best\" + 0.026*\"biosimilar\" + 0.025*\"approved\" + 0.022*\"approval\" + 0.021*\"disease\" + 0.021*\"linked\" + 0.019*\"autoimmune\"\n",
      "INFO:gensim.models.ldamodel:topic #13 (0.033): 0.074*\"humira\" + 0.057*\"psoriasis\" + 0.052*\"abbvie's\" + 0.048*\"fda\" + 0.040*\"severe\" + 0.038*\"fingernail\" + 0.037*\"moderate\" + 0.036*\"approves\" + 0.030*\"data\" + 0.026*\"addition\"\n",
      "INFO:gensim.models.ldamodel:topic #14 (0.033): 0.191*\"arthritis\" + 0.169*\"rheumatoid\" + 0.014*\"disease\" + 0.014*\"new\" + 0.013*\"help\" + 0.013*\"therapy\" + 0.010*\"diet\" + 0.010*\"autoimmune\" + 0.010*\"inflammation\" + 0.009*\"treatment\"\n",
      "INFO:gensim.models.ldamodel:topic #15 (0.033): 0.115*\"psoriasis\" + 0.059*\"skin\" + 0.030*\"eczema\" + 0.022*\"acne\" + 0.020*\"soap\" + 0.014*\"dry\" + 0.014*\"show\" + 0.012*\"care\" + 0.010*\"biologics\" + 0.010*\"adalimumab\"\n",
      "INFO:gensim.models.ldamodel:topic #16 (0.033): 0.033*\"time\" + 0.031*\"bristol\" + 0.025*\"myers\" + 0.023*\"insider\" + 0.021*\"ibrutinib\" + 0.018*\"usa\" + 0.018*\"buying\" + 0.018*\"head\" + 0.017*\"hits\" + 0.017*\"taking\"\n",
      "INFO:gensim.models.ldamodel:topic #17 (0.033): 0.036*\"imagine\" + 0.036*\"health\" + 0.031*\"reynolds\" + 0.031*\"dan\" + 0.030*\"made\" + 0.026*\"issues\" + 0.026*\"believer\" + 0.025*\"dragons\" + 0.024*\"life\" + 0.023*\"high\"\n",
      "INFO:gensim.models.ldamodel:topic #18 (0.033): 0.056*\"bristol\" + 0.052*\"myers\" + 0.049*\"squibb\" + 0.039*\"bmy\" + 0.029*\"executive\" + 0.028*\"appoints\" + 0.028*\"vice\" + 0.028*\"lynch\" + 0.027*\"bristolmyerssquibb\" + 0.026*\"read\"\n",
      "INFO:gensim.models.ldamodel:topic #19 (0.033): 0.087*\"biosimilar\" + 0.075*\"adalimumab\" + 0.062*\"equivalent\" + 0.060*\"efficacy\" + 0.057*\"sandoz\" + 0.054*\"data\" + 0.053*\"proposed\" + 0.052*\"new\" + 0.043*\"demonstrate\" + 0.026*\"humira\"\n",
      "INFO:gensim.models.ldamodel:topic #20 (0.033): 0.038*\"bristol\" + 0.033*\"myers\" + 0.032*\"read\" + 0.029*\"bmy\" + 0.028*\"squibb\" + 0.021*\"cancer\" + 0.021*\"opdivo\" + 0.020*\"bristolmyerssquibb\" + 0.020*\"shares\" + 0.016*\"receives\"\n",
      "INFO:gensim.models.ldamodel:topic #21 (0.033): 0.076*\"arthritis\" + 0.063*\"rheumatoid\" + 0.043*\"pain\" + 0.025*\"could\" + 0.020*\"drug\" + 0.019*\"joint\" + 0.018*\"new\" + 0.018*\"symptoms\" + 0.015*\"learn\" + 0.015*\"ibrutinib\"\n",
      "INFO:gensim.models.ldamodel:topic #22 (0.033): 0.053*\"hcv\" + 0.046*\"abbvie\" + 0.020*\"humira\" + 0.019*\"twitter\" + 0.018*\"via\" + 0.017*\"roche\" + 0.017*\"tops\" + 0.016*\"defence\" + 0.016*\"league\" + 0.015*\"patent\"\n",
      "INFO:gensim.models.ldamodel:topic #23 (0.033): 0.173*\"bristol\" + 0.167*\"myers\" + 0.138*\"squibb\" + 0.056*\"bmy\" + 0.034*\"new\" + 0.023*\"company\" + 0.023*\"chief\" + 0.017*\"would\" + 0.017*\"takeover\" + 0.016*\"massive\"\n",
      "INFO:gensim.models.ldamodel:topic #24 (0.033): 0.069*\"humira\" + 0.058*\"abbvie\" + 0.046*\"court\" + 0.035*\"biosimilars\" + 0.035*\"abbv\" + 0.033*\"patents\" + 0.033*\"good\" + 0.025*\"amgen\" + 0.025*\"market\" + 0.019*\"great\"\n",
      "INFO:gensim.models.ldamodel:topic #25 (0.033): 0.060*\"imbruvica\" + 0.039*\"tgtx\" + 0.035*\"sales\" + 0.032*\"abbvie\" + 0.027*\"therapy\" + 0.026*\"combo\" + 0.019*\"don't\" + 0.019*\"humira\" + 0.018*\"new\" + 0.018*\"like\"\n",
      "INFO:gensim.models.ldamodel:topic #26 (0.033): 0.053*\"study\" + 0.045*\"phase\" + 0.039*\"data\" + 0.039*\"positive\" + 0.037*\"tgtx\" + 0.035*\"ibrutinib\" + 0.029*\"combination\" + 0.028*\"genuine\" + 0.028*\"topline\" + 0.019*\"announces\"\n",
      "INFO:gensim.models.ldamodel:topic #27 (0.033): 0.105*\"spondylitis\" + 0.104*\"ankylosing\" + 0.040*\"hepatitis\" + 0.024*\"hcv\" + 0.023*\"i'm\" + 0.022*\"it's\" + 0.019*\"use\" + 0.015*\"humira\" + 0.013*\"diagnosed\" + 0.013*\"woundgod\"\n",
      "INFO:gensim.models.ldamodel:topic #28 (0.033): 0.145*\"inc\" + 0.107*\"abbvie\" + 0.086*\"abbv\" + 0.038*\"shares\" + 0.030*\"management\" + 0.029*\"llc\" + 0.027*\"stake\" + 0.025*\"position\" + 0.021*\"capital\" + 0.013*\"vetr\"\n",
      "INFO:gensim.models.ldamodel:topic #29 (0.033): 0.043*\"director\" + 0.026*\"development\" + 0.024*\"read\" + 0.023*\"blog\" + 0.021*\"need\" + 0.020*\"signs\" + 0.020*\"medicine\" + 0.018*\"focus\" + 0.018*\"investment\" + 0.018*\"psoriasis\"\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[(0,\n",
       "  '0.052*\"abbvie\" + 0.037*\"ibrutinib\" + 0.031*\"combo\" + 0.031*\"opinion\" + 0.031*\"cll\" + 0.028*\"phase\" + 0.027*\"treatment\" + 0.027*\"ublituximab\" + 0.027*\"chmp\" + 0.027*\"positive\"'),\n",
       " (1,\n",
       "  '0.087*\"humira\" + 0.082*\"abbvie\" + 0.037*\"continues\" + 0.035*\"attacked\" + 0.030*\"abbv\" + 0.019*\"price\" + 0.014*\"per\" + 0.013*\"i\\'m\" + 0.012*\"last\" + 0.012*\"enbrel\"'),\n",
       " (2,\n",
       "  '0.036*\"anti\" + 0.032*\"hcv\" + 0.029*\"inflammatory\" + 0.025*\"arthritis\" + 0.024*\"fight\" + 0.024*\"rheumatoid\" + 0.024*\"fatigue\" + 0.023*\"cancer\" + 0.023*\"flares\" + 0.022*\"cookbook\"'),\n",
       " (3,\n",
       "  '0.071*\"psoriasis\" + 0.030*\"like\" + 0.023*\"thanks\" + 0.020*\"today\" + 0.019*\"people\" + 0.016*\"humira\" + 0.014*\"find\" + 0.014*\"know\" + 0.014*\"day\" + 0.012*\"latest\"'),\n",
       " (4,\n",
       "  '0.040*\"abbvie\" + 0.027*\"top\" + 0.024*\"patients\" + 0.022*\"share\" + 0.019*\"story\" + 0.018*\"amgen\" + 0.016*\"news\" + 0.014*\"awareness\" + 0.014*\"hidradenitissuppurativa\" + 0.013*\"research\"'),\n",
       " (5,\n",
       "  '0.030*\"ibrutinib\" + 0.024*\"new\" + 0.023*\"partner\" + 0.020*\"cancer\" + 0.017*\"bms\" + 0.017*\"abbvie\" + 0.016*\"meeting\" + 0.016*\"amgen\" + 0.016*\"annual\" + 0.015*\"treatment\"'),\n",
       " (6,\n",
       "  '0.053*\"study\" + 0.050*\"amgen\\'s\" + 0.045*\"seen\" + 0.045*\"myeloma\" + 0.045*\"survival\" + 0.044*\"kyprolis\" + 0.043*\"velcade\" + 0.035*\"longer\" + 0.017*\"hcv\" + 0.014*\"non\"'),\n",
       " (7,\n",
       "  '0.071*\"humira\" + 0.030*\"abbvie\" + 0.027*\"psoriasis\" + 0.027*\"shows\" + 0.024*\"meets\" + 0.021*\"adalimumab\" + 0.020*\"research\" + 0.019*\"biosimilar\" + 0.018*\"efficacy\" + 0.018*\"cost\"'),\n",
       " (8,\n",
       "  '0.052*\"abbvie\" + 0.030*\"collaboration\" + 0.027*\"clinical\" + 0.018*\"new\" + 0.017*\"research\" + 0.016*\"patient\" + 0.015*\"announce\" + 0.014*\"hcv\" + 0.012*\"information\" + 0.012*\"healthcare\"'),\n",
       " (9,\n",
       "  '0.121*\"amgen\" + 0.074*\"jobs\" + 0.049*\"oaks\" + 0.045*\"marketing\" + 0.044*\"manager\" + 0.029*\"lgbtbizhub\" + 0.029*\"lgbtpro\" + 0.028*\"global\" + 0.024*\"senior\" + 0.020*\"sales\"'),\n",
       " (10,\n",
       "  '0.061*\"enbrel\" + 0.035*\"humira\" + 0.029*\"arthritis\" + 0.027*\"based\" + 0.023*\"rheumatoid\" + 0.019*\"fibromyalgia\" + 0.017*\"tea\" + 0.016*\"heals\" + 0.016*\"multiple\" + 0.015*\"amgen\"'),\n",
       " (11,\n",
       "  '0.047*\"ibrutinib\" + 0.047*\"psoriasis\" + 0.025*\"chronic\" + 0.025*\"abbv\" + 0.023*\"plaque\" + 0.022*\"lymphocytic\" + 0.020*\"symptoms\" + 0.020*\"abbvie\" + 0.019*\"leukemia\" + 0.017*\"tgtx\"'),\n",
       " (12,\n",
       "  '0.041*\"humira\" + 0.040*\"arthritis\" + 0.034*\"rheumatoid\" + 0.027*\"best\" + 0.026*\"biosimilar\" + 0.025*\"approved\" + 0.022*\"approval\" + 0.021*\"disease\" + 0.021*\"linked\" + 0.019*\"autoimmune\"'),\n",
       " (13,\n",
       "  '0.074*\"humira\" + 0.057*\"psoriasis\" + 0.052*\"abbvie\\'s\" + 0.048*\"fda\" + 0.040*\"severe\" + 0.038*\"fingernail\" + 0.037*\"moderate\" + 0.036*\"approves\" + 0.030*\"data\" + 0.026*\"addition\"'),\n",
       " (14,\n",
       "  '0.191*\"arthritis\" + 0.169*\"rheumatoid\" + 0.014*\"disease\" + 0.014*\"new\" + 0.013*\"help\" + 0.013*\"therapy\" + 0.010*\"diet\" + 0.010*\"autoimmune\" + 0.010*\"inflammation\" + 0.009*\"treatment\"'),\n",
       " (15,\n",
       "  '0.115*\"psoriasis\" + 0.059*\"skin\" + 0.030*\"eczema\" + 0.022*\"acne\" + 0.020*\"soap\" + 0.014*\"dry\" + 0.014*\"show\" + 0.012*\"care\" + 0.010*\"biologics\" + 0.010*\"adalimumab\"'),\n",
       " (16,\n",
       "  '0.033*\"time\" + 0.031*\"bristol\" + 0.025*\"myers\" + 0.023*\"insider\" + 0.021*\"ibrutinib\" + 0.018*\"usa\" + 0.018*\"buying\" + 0.018*\"head\" + 0.017*\"hits\" + 0.017*\"taking\"'),\n",
       " (17,\n",
       "  '0.036*\"imagine\" + 0.036*\"health\" + 0.031*\"reynolds\" + 0.031*\"dan\" + 0.030*\"made\" + 0.026*\"issues\" + 0.026*\"believer\" + 0.025*\"dragons\" + 0.024*\"life\" + 0.023*\"high\"'),\n",
       " (18,\n",
       "  '0.056*\"bristol\" + 0.052*\"myers\" + 0.049*\"squibb\" + 0.039*\"bmy\" + 0.029*\"executive\" + 0.028*\"appoints\" + 0.028*\"vice\" + 0.028*\"lynch\" + 0.027*\"bristolmyerssquibb\" + 0.026*\"read\"'),\n",
       " (19,\n",
       "  '0.087*\"biosimilar\" + 0.075*\"adalimumab\" + 0.062*\"equivalent\" + 0.060*\"efficacy\" + 0.057*\"sandoz\" + 0.054*\"data\" + 0.053*\"proposed\" + 0.052*\"new\" + 0.043*\"demonstrate\" + 0.026*\"humira\"'),\n",
       " (20,\n",
       "  '0.038*\"bristol\" + 0.033*\"myers\" + 0.032*\"read\" + 0.029*\"bmy\" + 0.028*\"squibb\" + 0.021*\"cancer\" + 0.021*\"opdivo\" + 0.020*\"bristolmyerssquibb\" + 0.020*\"shares\" + 0.016*\"receives\"'),\n",
       " (21,\n",
       "  '0.076*\"arthritis\" + 0.063*\"rheumatoid\" + 0.043*\"pain\" + 0.025*\"could\" + 0.020*\"drug\" + 0.019*\"joint\" + 0.018*\"new\" + 0.018*\"symptoms\" + 0.015*\"learn\" + 0.015*\"ibrutinib\"'),\n",
       " (22,\n",
       "  '0.053*\"hcv\" + 0.046*\"abbvie\" + 0.020*\"humira\" + 0.019*\"twitter\" + 0.018*\"via\" + 0.017*\"roche\" + 0.017*\"tops\" + 0.016*\"defence\" + 0.016*\"league\" + 0.015*\"patent\"'),\n",
       " (23,\n",
       "  '0.173*\"bristol\" + 0.167*\"myers\" + 0.138*\"squibb\" + 0.056*\"bmy\" + 0.034*\"new\" + 0.023*\"company\" + 0.023*\"chief\" + 0.017*\"would\" + 0.017*\"takeover\" + 0.016*\"massive\"'),\n",
       " (24,\n",
       "  '0.069*\"humira\" + 0.058*\"abbvie\" + 0.046*\"court\" + 0.035*\"biosimilars\" + 0.035*\"abbv\" + 0.033*\"patents\" + 0.033*\"good\" + 0.025*\"amgen\" + 0.025*\"market\" + 0.019*\"great\"'),\n",
       " (25,\n",
       "  '0.060*\"imbruvica\" + 0.039*\"tgtx\" + 0.035*\"sales\" + 0.032*\"abbvie\" + 0.027*\"therapy\" + 0.026*\"combo\" + 0.019*\"don\\'t\" + 0.019*\"humira\" + 0.018*\"new\" + 0.018*\"like\"'),\n",
       " (26,\n",
       "  '0.053*\"study\" + 0.045*\"phase\" + 0.039*\"data\" + 0.039*\"positive\" + 0.037*\"tgtx\" + 0.035*\"ibrutinib\" + 0.029*\"combination\" + 0.028*\"genuine\" + 0.028*\"topline\" + 0.019*\"announces\"'),\n",
       " (27,\n",
       "  '0.105*\"spondylitis\" + 0.104*\"ankylosing\" + 0.040*\"hepatitis\" + 0.024*\"hcv\" + 0.023*\"i\\'m\" + 0.022*\"it\\'s\" + 0.019*\"use\" + 0.015*\"humira\" + 0.013*\"diagnosed\" + 0.013*\"woundgod\"'),\n",
       " (28,\n",
       "  '0.145*\"inc\" + 0.107*\"abbvie\" + 0.086*\"abbv\" + 0.038*\"shares\" + 0.030*\"management\" + 0.029*\"llc\" + 0.027*\"stake\" + 0.025*\"position\" + 0.021*\"capital\" + 0.013*\"vetr\"'),\n",
       " (29,\n",
       "  '0.043*\"director\" + 0.026*\"development\" + 0.024*\"read\" + 0.023*\"blog\" + 0.021*\"need\" + 0.020*\"signs\" + 0.020*\"medicine\" + 0.018*\"focus\" + 0.018*\"investment\" + 0.018*\"psoriasis\"')]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lda.print_topics(30,10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "leukemia\n",
      "btk\n",
      "plcg2\n",
      "mutations\n",
      "cll\n",
      "relapse\n",
      "ibrutinib\n",
      "effective\n",
      "uveitis\n",
      "associated\n",
      "juvenile\n",
      "idiopathic\n",
      "arthritis\n",
      "bristol\n",
      "myers\n",
      "squibb's\n",
      "research\n",
      "liver\n",
      "disease\n",
      "presentation\n",
      "comment\n",
      "side\n",
      "effects\n",
      "humira\n",
      "adam\n",
      "nice\n",
      "site\n",
      "sensanders\n",
      "thank\n",
      "psoriatic\n",
      "drug\n",
      "take\n",
      "costs\n",
      "month\n",
      "enbrel\n",
      "amgen\n",
      "want\n",
      "learn\n",
      "clinical\n",
      "trials\n",
      "get\n",
      "facts\n",
      "clinicaltrials\n",
      "feel\n",
      "like\n",
      "form\n",
      "abbvie\n",
      "value\n",
      "makes\n",
      "difference\n",
      "bmsnews\n",
      "partnering\n",
      "exelixisinc\n",
      "late\n",
      "phase\n",
      "trial\n",
      "studies\n",
      "hcc\n",
      "bladder\n",
      "cancer\n",
      "bristolmyerssquibb\n",
      "exelixis\n",
      "links\n",
      "bms\n",
      "test\n",
      "potential\n",
      "combo\n",
      "read\n",
      "bmy\n",
      "true\n",
      "psoriasis\n",
      "feet\n",
      "hands\n",
      "scalp\n",
      "reaction\n",
      "top\n",
      "squibb\n",
      "company\n",
      "story\n",
      "swiss\n",
      "army\n",
      "knife\n",
      "pharmaceutical\n",
      "drugs\n",
      "university\n",
      "college\n",
      "dublin\n",
      "launch\n",
      "strategic\n",
      "partnership\n",
      "ucd\n",
      "talent\n",
      "development\n",
      "provide\n",
      "excellent\n",
      "next\n",
      "scientists\n",
      "insights\n",
      "adalimumab\n",
      "market\n",
      "global\n",
      "industry\n",
      "share\n",
      "trends\n",
      "application\n",
      "biosimilar\n",
      "strikes\n",
      "'outcomes'\n",
      "contract\n",
      "harvard\n",
      "pilgrim\n",
      "fiercepharma\n",
      "vetr\n",
      "users\n",
      "downgraded\n",
      "inc\n",
      "hold\n",
      "rating\n",
      "stars\n",
      "giving\n",
      "abbv\n",
      "target\n",
      "price\n",
      "asset\n",
      "management\n",
      "plc\n",
      "raises\n",
      "stake\n",
      "group\n",
      "sells\n",
      "shares\n",
      "bingham\n",
      "osborn\n",
      "scarborough\n",
      "llc\n",
      "increases\n",
      "bank\n",
      "lowers\n",
      "position\n",
      "deals\n",
      "alliances\n",
      "updated\n",
      "prices\n",
      "usd\n",
      "expands\n",
      "international\n",
      "immuno\n",
      "oncology\n",
      "network\n",
      "holdings\n",
      "corp\n",
      "care\n",
      "page\n",
      "area\n",
      "altman\n",
      "score\n",
      "analysis\n",
      "altmanzscore\n",
      "tops\n",
      "sees\n",
      "higher\n",
      "sales\n",
      "yeah\n",
      "i'm\n",
      "good\n",
      "waiting\n",
      "called\n",
      "look\n",
      "see\n",
      "done\n",
      "brief\n",
      "enanta\n",
      "says\n",
      "chmp\n",
      "gives\n",
      "positive\n",
      "opinion\n",
      "abbvie's\n",
      "hep\n",
      "treatment\n",
      "patients\n",
      "genotype\n",
      "devens\n",
      "health\n",
      "fitness\n",
      "center\n",
      "bristolmyers\n",
      "capital\n",
      "adds\n",
      "new\n",
      "partners\n",
      "senior\n",
      "workshop\n",
      "thanks\n",
      "sanofi\n",
      "walsh\n",
      "training\n",
      "biosimilars\n",
      "society\n",
      "stop\n",
      "patent\n",
      "abuse\n",
      "defend\n",
      "weakness\n",
      "product\n",
      "dyk\n",
      "involved\n",
      "clinicaltrial\n",
      "process\n",
      "important\n",
      "profits\n",
      "executives\n",
      "bonuses\n",
      "ibdwatch\n",
      "intra\n",
      "patient\n",
      "variability\n",
      "levels\n",
      "within\n",
      "ibd\n",
      "via\n",
      "app\n",
      "coäó_\n",
      "present\n",
      "barclays\n",
      "healthcare\n",
      "conference\n",
      "signs\n",
      "based\n",
      "deal\n",
      "amgn\n",
      "investopedia\n",
      "pharmamktnet\n",
      "focus\n",
      "precision\n",
      "medicine\n",
      "investment\n",
      "planned\n",
      "collaboration\n",
      "grail\n",
      "blood\n",
      "screening\n",
      "drugdiscovery\n",
      "news\n",
      "oną\n",
      "carl\n",
      "icahn\n",
      "takes\n",
      "stocks\n",
      "gild\n",
      "announced\n",
      "columbia\n",
      "medical\n",
      "peter\n",
      "maccallum\n",
      "centre\n",
      "announces\n",
      "equity\n",
      "'brief\n",
      "business\n",
      "bloomberg\n",
      "lucky\n",
      "changed\n",
      "life\n",
      "able\n",
      "work\n",
      "advice\n",
      "rheum\n",
      "first\n",
      "time\n",
      "user\n",
      "tonight\n",
      "night\n",
      "hires\n",
      "gene\n",
      "therapy\n",
      "legendąşand\n",
      "big\n",
      "biotech\n",
      "disruptorąşrichard\n",
      "mulligan\n",
      "rumors\n",
      "simmer\n",
      "thought\n",
      "don't\n",
      "tons\n",
      "prednisone\n",
      "enter\n",
      "outcomes\n",
      "fantastic\n",
      "meet\n",
      "great\n",
      "chat\n",
      "community\n",
      "hepc\n",
      "services\n",
      "guy\n",
      "support\n",
      "campaign\n",
      "protecting\n",
      "skin\n",
      "sun\n",
      "immunooncology\n",
      "diagnostics\n",
      "coą\n",
      "medisien\n",
      "täó_\n",
      "äó_\n",
      "meeting\n",
      "honored\n",
      "hear\n",
      "rash\n",
      "fun\n",
      "lol\n",
      "we're\n",
      "proud\n",
      "announce\n",
      "joining\n",
      "swirl\n",
      "puts\n",
      "legend\n",
      "payroll\n",
      "taking\n",
      "precisionmedicine\n",
      "nurse\n",
      "spoke\n",
      "dallas\n",
      "highlight\n",
      "trip\n",
      "production\n",
      "problems\n",
      "anti\n",
      "stock\n",
      "lowered\n",
      "pact\n",
      "last\n",
      "least\n",
      "talk\n",
      "david\n",
      "chronic\n",
      "gvhd\n",
      "myersą\n",
      "high\n",
      "risk\n",
      "return\n",
      "bet\n",
      "azn\n",
      "exel\n",
      "mrk\n",
      "rhhby\n",
      "seekingalpha\n",
      "hcv\n",
      "week\n",
      "ema\n",
      "panel\n",
      "viekirax\n",
      "exviera\n",
      "receives\n",
      "mar\n",
      "acquired\n",
      "resistance\n",
      "waldenstrom\n",
      "macroglobulinemia\n",
      "forget\n",
      "submit\n",
      "immunology\n",
      "scholarship\n",
      "submissions\n",
      "due\n",
      "partner\n",
      "education\n",
      "including\n",
      "stem\n",
      "csr\n",
      "icymi\n",
      "brand\n",
      "today\n",
      "people\n",
      "biologics\n",
      "complete\n",
      "personalized\n",
      "wellness\n",
      "nyse\n",
      "bllshbrsh\n",
      "release\n",
      "bloodbased\n",
      "genentech\n",
      "dominate\n",
      "franchise\n",
      "image\n",
      "overall\n",
      "engagement\n",
      "among\n",
      "oncologists\n",
      "biology\n",
      "science\n",
      "finance\n",
      "increased\n",
      "analyst\n",
      "cancerą\n",
      "press\n",
      "melanoma\n",
      "chemotherapy\n",
      "frontline\n",
      "lymphocytic\n",
      "promising\n",
      "data\n",
      "study\n",
      "ktokmf4si2\n",
      "come\n",
      "may\n",
      "help\n",
      "tofacitinib\n",
      "non\n",
      "rheumatoidarthritis\n",
      "click\n",
      "details\n",
      "pharmatimes\n",
      "opdivo\n",
      "start\n",
      "roche\n",
      "energy\n",
      "insurance\n",
      "i've\n",
      "worth\n",
      "doses\n",
      "guys\n",
      "cool\n",
      "everyday\n",
      "medsminders\n",
      "meds\n",
      "reminder\n",
      "hiv\n",
      "botox\n",
      "glucerna\n",
      "us_fda\n",
      "approves\n",
      "relapsed\n",
      "refractory\n",
      "marginal\n",
      "zone\n",
      "lymphoma\n",
      "lymsm\n",
      "long\n",
      "term\n",
      "efficacy\n",
      "safety\n",
      "pediatric\n",
      "crohn's\n",
      "can't\n",
      "wait\n",
      "north\n",
      "chicago\n",
      "real\n",
      "world\n",
      "shows\n",
      "similar\n",
      "infliximab\n",
      "use\n",
      "man\n",
      "sat\n",
      "ads\n",
      "past\n",
      "hour\n",
      "awful\n",
      "might\n",
      "women\n",
      "school\n",
      "iwd17\n",
      "womenshistorymonth\n",
      "buy\n",
      "working\n",
      "academy\n",
      "celebrate\n",
      "winners\n",
      "force\n",
      "generation\n",
      "foundation\n",
      "lack\n",
      "hematology\n",
      "iną\n",
      "biopharmaceutical\n",
      "let's\n",
      "continue\n",
      "leadership\n",
      "diversity\n",
      "bring\n",
      "passion\n",
      "join\n",
      "wednesdaywisdom\n",
      "role\n",
      "models\n",
      "love\n",
      "ties\n",
      "gilead\n",
      "raise\n",
      "questions\n",
      "merck\n",
      "targeting\n",
      "didn't\n",
      "left\n",
      "job\n",
      "run\n",
      "actual\n",
      "researchers\n",
      "started\n",
      "friend\n",
      "immune\n",
      "system\n",
      "turns\n",
      "turn\n",
      "back\n",
      "jia\n",
      "find\n",
      "close\n",
      "march\n",
      "dividend\n",
      "invest\n",
      "income\n",
      "looking\n",
      "cost\n",
      "solution\n",
      "biogen\n",
      "pfizer\n",
      "diabetes\n",
      "it's\n",
      "matter\n",
      "death\n",
      "jnj\n",
      "better\n",
      "johnson\n",
      "treatments\n",
      "otezla\n",
      "stelara\n",
      "making\n",
      "moves\n",
      "seems\n",
      "i'll\n",
      "place\n",
      "orencia\n",
      "found\n",
      "article\n",
      "ankylosing\n",
      "spondylitis\n",
      "activist\n",
      "investors\n",
      "seem\n",
      "interested\n",
      "check\n",
      "latest\n",
      "corporate\n",
      "outlook\n",
      "service\n",
      "delivery\n",
      "leader\n",
      "tampa\n",
      "surgical\n",
      "eye\n",
      "surgery\n",
      "buys\n",
      "adding\n",
      "pressure\n",
      "effect\n",
      "final\n",
      "secondary\n",
      "patents\n",
      "sandoz\n",
      "decision\n",
      "met\n",
      "usa\n",
      "switzerland\n",
      "nexium\n",
      "canada\n",
      "grants\n",
      "priority\n",
      "review\n",
      "hepatitis\n",
      "candidate\n",
      "took\n",
      "dose\n",
      "diagnosed\n",
      "wish\n",
      "luck\n",
      "inhibition\n",
      "prevention\n",
      "versus\n",
      "host\n",
      "mice\n",
      "developed\n",
      "since\n",
      "starting\n",
      "super\n",
      "show\n",
      "icahn's\n",
      "offers\n",
      "little\n",
      "benefits\n",
      "men\n",
      "team\n",
      "linked\n",
      "either\n",
      "followers\n",
      "suffer\n",
      "severe\n",
      "trying\n",
      "inject\n",
      "_ôö\n",
      "acn\n",
      "gets\n",
      "option\n",
      "single\n",
      "agent\n",
      "leads\n",
      "liked\n",
      "youtube\n",
      "video\n",
      "pre\n",
      "syringe\n",
      "shot\n",
      "reuters\n",
      "starts\n",
      "day\n",
      "building\n",
      "recent\n",
      "reveals\n",
      "make\n",
      "grant\n",
      "crohns\n",
      "tried\n",
      "let\n",
      "know\n",
      "many\n",
      "bad\n",
      "comes\n",
      "iii\n",
      "sell\n",
      "unit\n",
      "etanercept\n",
      "toäó_\n",
      "free\n",
      "chroniclife\n",
      "interesting\n",
      "scriplucie\n",
      "future\n",
      "manage\n",
      "arrow\n",
      "valuable\n",
      "hits\n",
      "home\n",
      "sense\n",
      "showed\n",
      "significant\n",
      "increase\n",
      "orr\n",
      "imbruvica\n",
      "huge\n",
      "improve\n",
      "tgtx\n",
      "short\n",
      "wen\n",
      "strong\n",
      "improving\n",
      "question\n",
      "needs\n",
      "used\n",
      "rate\n",
      "releases\n",
      "journal\n",
      "novartis\n",
      "nvs\n",
      "reports\n",
      "ground\n",
      "breaking\n",
      "declaratory\n",
      "relief\n",
      "english\n",
      "court\n",
      "clears\n",
      "route\n",
      "anyone\n",
      "pharmacy\n",
      "call\n",
      "relation\n",
      "dosage\n",
      "regimes\n",
      "blog\n",
      "small\n",
      "numbers\n",
      "others\n",
      "rituxan\n",
      "invalidates\n",
      "hate\n",
      "known\n",
      "active\n",
      "update\n",
      "shots\n",
      "_ô_\n",
      "days\n",
      "without\n",
      "affect\n",
      "miss\n",
      "serious\n",
      "infections\n",
      "loss\n",
      "date\n",
      "feeling\n",
      "breath\n",
      "induced\n",
      "lung\n",
      "needed\n",
      "put\n",
      "halo\n",
      "dropped\n",
      "nhs\n",
      "pays\n",
      "thing\n",
      "topline\n",
      "genuine\n",
      "combination\n",
      "pharmacyclics\n",
      "longtime\n",
      "developing\n",
      "options\n",
      "amazing\n",
      "fatigue\n",
      "phil\n",
      "tnf\n",
      "alpha\n",
      "inhibitor\n",
      "exist\n",
      "eczema\n",
      "heard\n",
      "best\n",
      "results\n",
      "try\n",
      "_ôď\n",
      "dollars\n",
      "presents\n",
      "highlights\n",
      "treating\n",
      "mesgreene\n",
      "terezhumphrey\n",
      "hand\n",
      "pain\n",
      "perfect\n",
      "hope\n",
      "asking\n",
      "learned\n",
      "affected\n",
      "info\n",
      "moving\n",
      "per\n",
      "symptoms\n",
      "years\n",
      "much\n",
      "remicade\n",
      "doesn't\n",
      "mtx\n",
      "antibodies\n",
      "worse\n",
      "plus\n",
      "full\n",
      "rheumy\n",
      "blow\n",
      "opened\n",
      "wide\n",
      "psa\n",
      "causes\n",
      "danjamesstanton\n",
      "rules\n",
      "samsung\n",
      "fujifilm\n",
      "mom\n",
      "tell\n",
      "cause\n",
      "thats\n",
      "goodwinlaw\n",
      "mother\n",
      "daughter\n",
      "helping\n",
      "induce\n",
      "tolerance\n",
      "eyes\n",
      "worst\n",
      "post\n",
      "elderly\n",
      "helped\n",
      "new2trip\n",
      "treated\n",
      "leukaemia\n",
      "untreated\n",
      "hello\n",
      "haven't\n",
      "inflammation\n",
      "regulatory\n",
      "cells\n",
      "mitchellvii\n",
      "remember\n",
      "given\n",
      "early\n",
      "current\n",
      "mkt\n",
      "hard\n",
      "include\n",
      "agents\n",
      "venetoclax\n",
      "plan\n",
      "simple\n",
      "mind\n",
      "year\n",
      "weekly\n",
      "injection\n",
      "surprise\n",
      "think\n",
      "anything\n",
      "pay\n",
      "nothing\n",
      "ask\n",
      "insider\n",
      "trading\n",
      "combinations\n",
      "idelalisib\n",
      "lupus\n",
      "seen\n",
      "weight\n",
      "rheumerhasit\n",
      "systems\n",
      "different\n",
      "complex\n",
      "xeljanz\n",
      "expensive\n",
      "yrs\n",
      "got\n",
      "set\n",
      "injections\n",
      "httpsäó_\n",
      "pfs\n",
      "case\n",
      "wondering\n",
      "feels\n",
      "you're\n",
      "every\n",
      "weeks\n",
      "need\n",
      "paying\n",
      "medication\n",
      "ublituximab\n",
      "succeeds\n",
      "reported\n",
      "therapeutic\n",
      "indication\n",
      "benefit\n",
      "assessment\n",
      "according\n",
      "social\n",
      "code\n",
      "book\n",
      "mckee_heathir\n",
      "add\n",
      "steroids\n",
      "chemo\n",
      "mediated\n",
      "acquisition\n",
      "experience\n",
      "heart\n",
      "right\n",
      "jobs\n",
      "director\n",
      "marketing\n",
      "consumer\n",
      "lead\n",
      "oaks\n",
      "mgr\n",
      "rheumatology\n",
      "lgbtpro\n",
      "lgbtbizhub\n",
      "sorry\n",
      "son\n",
      "allergic\n",
      "thankful\n",
      "girl\n",
      "months\n",
      "_ôí\n",
      "needle\n",
      "thigh\n",
      "guess\n",
      "chronicpain\n",
      "happy\n",
      "program\n",
      "worried\n",
      "old\n",
      "orphan\n",
      "bloodjournal\n",
      "burns\n",
      "made\n",
      "switch\n",
      "trilipix\n",
      "folks\n",
      "abc\n",
      "woman\n",
      "came\n",
      "seeing\n",
      "went\n",
      "rheumatoid\n",
      "meets\n",
      "primary\n",
      "endpoints\n",
      "hey\n",
      "everyone\n",
      "felt\n",
      "bowel\n",
      "media\n",
      "aacr17\n",
      "bmsataacr\n",
      "advances\n",
      "understanding\n",
      "therapies\n",
      "ema_news\n",
      "nloatlqpyn\n",
      "oncologytube\n",
      "follow\n",
      "tablet\n",
      "earnings\n",
      "report\n",
      "pharma\n",
      "boost\n",
      "skills\n",
      "farmers\n",
      "merchants\n",
      "trust\n",
      "chambersburg\n",
      "invests\n",
      "watch\n",
      "inspiring\n",
      "hurt\n",
      "national\n",
      "planning\n",
      "lots\n",
      "foods\n",
      "alliance\n",
      "ltd\n",
      "shout\n",
      "companies\n",
      "list\n",
      "cut\n",
      "holdąą\n",
      "detection\n",
      "using\n",
      "mobility\n",
      "shift\n",
      "piece\n",
      "linkedin\n",
      "discussion\n",
      "seananstee\n",
      "burnhamformayor\n",
      "janebrophyld\n",
      "thercn\n",
      "salforduni\n",
      "healthcarehustings\n",
      "weążre\n",
      "conditions\n",
      "alzheimers\n",
      "ojosdotcom\n",
      "biotechie_com\n",
      "clean\n",
      "associates\n",
      "backed\n",
      "amazon\n",
      "names\n",
      "celgene\n",
      "bay\n",
      "area's\n",
      "banks\n",
      "chs\n",
      "healthy\n",
      "discusses\n",
      "common\n",
      "pts\n",
      "progression\n",
      "upside\n",
      "newingtoncomms\n",
      "theą\n",
      "pipeline\n",
      "project\n",
      "siliconrepublic\n",
      "open\n",
      "source\n",
      "resource\n",
      "'the\n",
      "congratulations\n",
      "agreement\n",
      "address\n",
      "africa\n",
      "conherus'\n",
      "successful\n",
      "bioequivalence\n",
      "chrs\n",
      "effe\n",
      "marketcurrents\n",
      "financial\n",
      "technology\n",
      "population\n",
      "warning\n",
      "looks\n",
      "name\n",
      "itchy\n",
      "stage\n",
      "line\n",
      "renal\n",
      "cell\n",
      "carcinoma\n",
      "highs\n",
      "change\n",
      "pick\n",
      "could\n",
      "something\n",
      "works\n",
      "failed\n",
      "dna\n",
      "tumors\n",
      "highlighted\n",
      "baricitinib\n",
      "fda\n",
      "fall\n",
      "relevant\n",
      "another\n",
      "coherus\n",
      "henryechang\n",
      "ptv\n",
      "owning\n",
      "less\n",
      "buyout\n",
      "pfe\n",
      "begins\n",
      "build\n",
      "herceptin\n",
      "would\n",
      "keep\n",
      "pass\n",
      "clinic\n",
      "directors\n",
      "plans\n",
      "advance\n",
      "ready\n",
      "house\n",
      "muniya_b\n",
      "innovative\n",
      "way\n",
      "setting\n",
      "abbvieążs\n",
      "lawrence\n",
      "busy\n",
      "immunooncolo\n",
      "clinicalapprovals\n",
      "purchases\n",
      "httpsą\n",
      "rolls\n",
      "phiii\n",
      "matching\n",
      "cabo\n",
      "checkpoint\n",
      "httą\n",
      "veterans\n",
      "ulcerativecolitis\n",
      "spring\n",
      "career\n",
      "registration\n",
      "required\n",
      "digital\n",
      "revenue\n",
      "alone\n",
      "double\n",
      "paid\n",
      "hopewell\n",
      "township\n",
      "public\n",
      "input\n",
      "sought\n",
      "oil\n",
      "bed\n",
      "europe\n",
      "comfort\n",
      "disability\n",
      "supply\n",
      "sofosbuvir\n",
      "hit\n",
      "tomorrow\n",
      "catch\n",
      "minutes\n",
      "class\n",
      "methotrexate\n",
      "red\n",
      "learning\n",
      "act\n",
      "engage\n",
      "success\n",
      "declares\n",
      "quarterly\n",
      "older\n",
      "member\n",
      "moderate\n",
      "threat\n",
      "sciences\n",
      "approval\n",
      "eliquis\n",
      "prophylaxis\n",
      "car\n",
      "blinatumomab\n",
      "getting\n",
      "tonight's\n",
      "cooking\n",
      "thx\n",
      "sponsors\n",
      "sustained\n",
      "biosimcenter\n",
      "guidance\n",
      "naming\n",
      "visit\n",
      "french\n",
      "welcome\n",
      "activity\n",
      "bought\n",
      "things\n",
      "newsroom\n",
      "sore\n",
      "diseases\n",
      "'you\n",
      "become\n",
      "intolerant\n",
      "cäó_\n",
      "deletion\n",
      "content\n",
      "parkinson's\n",
      "prescription\n",
      "stress\n",
      "god\n",
      "nassexercise\n",
      "stopped\n",
      "wasn't\n",
      "isn't\n",
      "stay\n",
      "dermatologist\n",
      "funding\n",
      "competition\n",
      "going\n",
      "wednesday\n",
      "worked\n",
      "pharmaceuticals\n",
      "oral\n",
      "strategy\n",
      "compared\n",
      "battle\n",
      "stand\n",
      "challenge\n",
      "investing\n",
      "stopping\n",
      "you've\n",
      "answer\n",
      "stockbroker\n",
      "existing\n",
      "break\n",
      "pricing\n",
      "compression\n",
      "give\n",
      "august\n",
      "theseatedview\n",
      "dear\n",
      "possible\n",
      "pls\n",
      "choice\n",
      "outperforms\n",
      "progress\n",
      "growth\n",
      "reason\n",
      "legal\n",
      "delay\n",
      "head\n",
      "won't\n",
      "daily\n",
      "products\n",
      "worldwide\n",
      "crestor\n",
      "abilify\n",
      "passes\n",
      "sure\n",
      "humira'sabbvie\n",
      "pursues\n",
      "shareholders\n",
      "interests\n",
      "npwm6oz7yi\n",
      "opsoms\n",
      "edwardloftus2\n",
      "tdm\n",
      "vedolizumab\n",
      "helps\n",
      "suffering\n",
      "seek\n",
      "looms\n",
      "approved\n",
      "second\n",
      "hopes\n",
      "interest\n",
      "nass\n",
      "flare\n",
      "hall\n",
      "changes\n",
      "develop\n",
      "headaches\n",
      "makers\n",
      "performance\n",
      "approach\n",
      "comparison\n",
      "suggests\n",
      "claim\n",
      "speak\n",
      "doctor\n",
      "telling\n",
      "rheumatologynet\n",
      "supposed\n",
      "thursday\n",
      "biologic\n",
      "getgutsycanada\n",
      "following\n",
      "taken\n",
      "sick\n",
      "cafepharma\n",
      "detail\n",
      "food\n",
      "amgen's\n",
      "response\n",
      "kind\n",
      "autoimmunedisease\n",
      "annemarievtw\n",
      "earn\n",
      "infusion\n",
      "order\n",
      "commercials\n",
      "episodes\n",
      "entyvio\n",
      "scary\n",
      "former\n",
      "wow\n",
      "believe\n",
      "shit\n",
      "hospital\n",
      "backs\n",
      "treat\n",
      "fish\n",
      "investigational\n",
      "spoonieproblems\n",
      "fighting\n",
      "half\n",
      "ends\n",
      "kitchen\n",
      "related\n",
      "observational\n",
      "drraulcordoba\n",
      "persons\n",
      "wanted\n",
      "headache\n",
      "lot\n",
      "sister\n",
      "afford\n",
      "wrong\n",
      "squamous\n",
      "arm\n",
      "body\n",
      "lovely\n",
      "taltz\n",
      "painful\n",
      "track\n",
      "record\n",
      "giants\n",
      "findings\n",
      "type\n",
      "struggling\n",
      "pharma's\n",
      "activists\n",
      "myers'\n",
      "february\n",
      "appoints\n",
      "independent\n",
      "events\n",
      "takeover\n",
      "remains\n",
      "advanced\n",
      "auto\n",
      "approvals\n",
      "cann\n",
      "outperform\n",
      "several\n",
      "analysts\n",
      "bmo\n",
      "markets\n",
      "astrazeneca\n",
      "solid\n",
      "main\n",
      "street\n",
      "acquires\n",
      "investments\n",
      "key\n",
      "players\n",
      "laboratories\n",
      "ombitasvir\n",
      "expected\n",
      "enta\n",
      "changing\n",
      "ireland\n",
      "decreased\n",
      "twin\n",
      "suppression\n",
      "addition\n",
      "highland\n",
      "wealth\n",
      "sold\n",
      "intern\n",
      "mba\n",
      "european\n",
      "advisory\n",
      "committee\n",
      "shorter\n",
      "regimen\n",
      "premarket\n",
      "clarius\n",
      "star\n",
      "state\n",
      "board\n",
      "administration\n",
      "florida\n",
      "retirement\n",
      "breast\n",
      "iion\n",
      "latestage\n",
      "hepatology\n",
      "biopharmadive\n",
      "reading\n",
      "failure\n",
      "universityą\n",
      "renalą\n",
      "medicboard\n",
      "favorite\n",
      "fight\n",
      "initiative\n",
      "pop\n",
      "spending\n",
      "medtech\n",
      "onmedic\n",
      "ehealth\n",
      "granted\n",
      "permanent\n",
      "repatha\n",
      "channel\n",
      "information\n",
      "wins\n",
      "authorization\n",
      "students\n",
      "reach\n",
      "action\n",
      "manager\n",
      "buying\n",
      "excited\n",
      "morning\n",
      "shopping\n",
      "kidney\n",
      "prnewswire\n",
      "brown\n",
      "ofą\n",
      "ceo\n",
      "likely\n",
      "win\n",
      "dive\n",
      "aarp\n",
      "eli\n",
      "regeneron\n",
      "cholesterol\n",
      "file\n",
      "amicus\n",
      "briefs\n",
      "part\n",
      "cowen\n",
      "annual\n",
      "closes\n",
      "debt\n",
      "offering\n",
      "edge\n",
      "scientific\n",
      "apply\n",
      "showing\n",
      "yahoofinance\n",
      "files\n",
      "benepali\n",
      "pen\n",
      "optimal\n",
      "novel\n",
      "goes\n",
      "kyprolis\n",
      "blincyto\n",
      "recommends\n",
      "infection\n",
      "hiring\n",
      "opportunity\n",
      "ingredients\n",
      "api\n",
      "boehringer\n",
      "ingelheim\n",
      "play\n",
      "spots\n",
      "amgentoc\n",
      "race\n",
      "chance\n",
      "access\n",
      "infectious\n",
      "pivotal\n",
      "pharmacyleadership\n",
      "april\n",
      "incidence\n",
      "america\n",
      "affairs\n",
      "cure\n",
      "mylan\n",
      "apotex\n",
      "adello\n",
      "united\n",
      "states\n",
      "filed\n",
      "molecular\n",
      "pregnancy\n",
      "pregnant\n",
      "medications\n",
      "jump\n",
      "cnbc\n",
      "med\n",
      "inhibitors\n",
      "shown\n",
      "mzl\n",
      "expert\n",
      "googlealerts\n",
      "wont\n",
      "pleased\n",
      "joined\n",
      "rarediseaseday\n",
      "molecule\n",
      "association\n",
      "chain\n",
      "human\n",
      "genome\n",
      "california\n",
      "jumps\n",
      "amgenfoundation\n",
      "vera\n",
      "journey\n",
      "concerning\n",
      "aid\n",
      "genomic\n",
      "biopharma\n",
      "quality\n",
      "coming\n",
      "deadline\n",
      "level\n",
      "euro\n",
      "gsk\n",
      "feb\n",
      "around\n",
      "combined\n",
      "minimal\n",
      "fibrosis\n",
      "wonder\n",
      "he's\n",
      "beyond\n",
      "living\n",
      "earns\n",
      "charge\n",
      "discuss\n",
      "lawsuit\n",
      "baby\n",
      "replace\n",
      "biomarkers\n",
      "perrigo\n",
      "cfo\n",
      "adults\n",
      "resigns\n",
      "ago\n",
      "upper\n",
      "along\n",
      "poor\n",
      "rough\n",
      "nursing\n",
      "tissue\n",
      "tumor\n",
      "scoopit\n",
      "kept\n",
      "remission\n",
      "japan\n",
      "protein\n",
      "endpoint\n",
      "judy\n",
      "leaving\n",
      "wsj\n",
      "ustekinumab\n",
      "series\n",
      "httpäó_\n",
      "associate\n",
      "evidence\n",
      "solutions\n",
      "rep\n",
      "counsel\n",
      "adverse\n",
      "event\n",
      "mint\n",
      "across\n",
      "adv\n",
      "breakawayhd\n",
      "bringing\n",
      "awareness\n",
      "cuts\n",
      "royalties\n",
      "loses\n",
      "lymphomahub\n",
      "bitch\n",
      "fuck\n",
      "longer\n",
      "survival\n",
      "takeda's\n",
      "velcade\n",
      "myeloma\n",
      "box\n",
      "multiple\n",
      "inc's\n",
      "received\n",
      "groups\n",
      "supporting\n",
      "history\n",
      "what's\n",
      "pioneer\n",
      "motley\n",
      "fool\n",
      "beats\n",
      "tkphf\n",
      "tkpyy\n",
      "ratings\n",
      "nasdaq\n",
      "confirm\n",
      "superiority\n",
      "shared\n",
      "minimize\n",
      "children\n",
      "receive\n",
      "rise\n",
      "innovation\n",
      "newadisinsight\n",
      "eu_commission\n",
      "condition\n",
      "cured\n",
      "jamie_love\n",
      "percent\n",
      "jennifer\n",
      "tour\n",
      "joins\n",
      "official\n",
      "office\n",
      "ice\n",
      "commercial\n",
      "fucking\n",
      "times\n",
      "factor\n",
      "means\n",
      "lower\n",
      "that's\n",
      "general\n",
      "sny\n",
      "scotus\n",
      "alert\n",
      "keeps\n",
      "control\n",
      "scientist\n",
      "sclerosis\n",
      "germany\n",
      "bit\n",
      "topped\n",
      "person\n",
      "engineer\n",
      "reiterated\n",
      "monthly\n",
      "plays\n",
      "saving\n",
      "lives\n",
      "city\n",
      "amgenążs\n",
      "careers\n",
      "aca\n",
      "sad\n",
      "american\n",
      "selling\n",
      "americans\n",
      "reporting\n",
      "summary\n",
      "realdonaldtrump\n",
      "told\n",
      "fast\n",
      "money\n",
      "trade\n",
      "sponsor\n",
      "register\n",
      "understand\n",
      "congrats\n",
      "south\n",
      "gotta\n",
      "weird\n",
      "notice\n",
      "happen\n",
      "offer\n",
      "company's\n",
      "fail\n",
      "recommended\n",
      "yesterday\n",
      "therapeutics\n",
      "nivolumab\n",
      "executive\n",
      "impact\n",
      "princeton\n",
      "operations\n",
      "specialist\n",
      "mantle\n",
      "mcl\n",
      "sickness\n",
      "rare\n",
      "dermatology\n",
      "summer\n",
      "stanbul\n",
      "asya\n",
      "com\n",
      "reduce\n",
      "goat\n",
      "synthroid\n",
      "href\n",
      "'http\n",
      "twitter\n",
      "download\n",
      "iphone'\n",
      "rel\n",
      "'nofollow'\n",
      "iphone\n",
      "blue\n",
      "we've\n",
      "exciting\n",
      "sign\n",
      "ankylosingspondylitis\n",
      "hbv\n",
      "impacts\n",
      "reduces\n",
      "highest\n",
      "winning\n",
      "awards\n",
      "baclofen\n",
      "alcohol\n",
      "hepatitisc\n",
      "hiv_insight\n",
      "upcoming\n",
      "incoming\n",
      "canadian\n",
      "sentenced\n",
      "physical\n",
      "cross\n",
      "acid\n",
      "contributes\n",
      "gut\n",
      "microbiota\n",
      "pathogenesis\n",
      "boys\n",
      "basketball\n",
      "defeats\n",
      "thompson\n",
      "osteoporosis\n",
      "running\n",
      "please\n",
      "donate\n",
      "word\n",
      "spoonie\n",
      "dan\n",
      "reynolds\n",
      "transplant\n",
      "testing\n",
      "rates\n",
      "virus\n",
      "must\n",
      "advocates\n",
      "italy\n",
      "advocate\n",
      "fact\n",
      "realized\n",
      "dreams\n",
      "retweet\n",
      "someone\n",
      "fails\n",
      "doug\n",
      "dieterich\n",
      "sof\n",
      "vel\n",
      "vox\n",
      "experienced\n",
      "decline\n",
      "acute\n",
      "dutch\n",
      "msm\n",
      "daa\n",
      "juergen\n",
      "rockstroh\n",
      "croi\n",
      "round\n",
      "paper\n",
      "published\n",
      "viral\n",
      "load\n",
      "effectiveness\n",
      "antiviral\n",
      "cohort\n",
      "macrophages\n",
      "consultation\n",
      "stories\n",
      "heil\n",
      "storm\n",
      "comic\n",
      "repeal\n",
      "lgbt\n",
      "beauty\n",
      "healthline\n",
      "martin\n",
      "imagine\n",
      "dragons\n",
      "face\n",
      "managing\n",
      "coinfection\n",
      "endhepatitis\n",
      "finds\n",
      "appear\n",
      "types\n",
      "available\n",
      "generic\n",
      "tested\n",
      "mental\n",
      "sync'ing\n",
      "speaks\n",
      "imaginedragons\n",
      "singer\n",
      "danreynolds\n",
      "opens\n",
      "struggle\n",
      "thisaslife\n",
      "award\n",
      "expand\n",
      "third\n",
      "roll\n",
      "low\n",
      "boomers\n",
      "president\n",
      "technical\n",
      "elimination\n",
      "saw\n",
      "section\n",
      "link\n",
      "participation\n",
      "cases\n",
      "mortality\n",
      "brain\n",
      "sync2017\n",
      "betty\n",
      "tourney\n",
      "course\n",
      "knew\n",
      "easier\n",
      "infected\n",
      "hcvburros\n",
      "interferon\n",
      "regimens\n",
      "awesome\n",
      "texas\n",
      "burroshillsboro\n",
      "region\n",
      "beat\n",
      "looming\n",
      "programming\n",
      "dragons'\n",
      "projectecho\n",
      "diet\n",
      "diagnosis\n",
      "seronegative\n",
      "reactive\n",
      "minot\n",
      "factors\n",
      "placebo\n",
      "controlled\n",
      "tests\n",
      "jhepatology\n",
      "corrigendum\n",
      "direct\n",
      "acting\n",
      "antivirals\n",
      "expect\n",
      "major\n",
      "improvements\n",
      "nmsonblk9k\n",
      "android'\n",
      "android\n",
      "com'\n",
      "web\n",
      "client\n",
      "lost\n",
      "plaque\n",
      "neue\n",
      "therapieoption\n",
      "seit\n",
      "märz\n",
      "verfügbar\n",
      "members\n",
      "vehicle\n",
      "segment\n",
      "backpain\n",
      "issues\n",
      "believer\n",
      "overview\n",
      "breaks\n",
      "silence\n",
      "consider\n",
      "practical\n",
      "thedoctors\n",
      "discussing\n",
      "sessions\n",
      "plant\n",
      "spineuniverse\n",
      "though\n",
      "tho\n",
      "doctors\n",
      "raising\n",
      "poster\n",
      "joint\n",
      "slow\n",
      "tips\n",
      "optimizing\n",
      "pharmacist\n",
      "caused\n",
      "genotypes\n",
      "opening\n",
      "country\n",
      "promise\n",
      "herb\n",
      "asthma\n",
      "imaging\n",
      "syndrome\n",
      "john\n",
      "damage\n",
      "healiogastro\n",
      "schuppenflechte\n",
      "dermatitis\n",
      "daas\n",
      "gave\n",
      "improvement\n",
      "grade\n",
      "funds\n",
      "reduced\n",
      "wake\n",
      "setbacks\n",
      "speaking\n",
      "lifting\n",
      "advisor\n",
      "black\n",
      "yes\n",
      "live\n",
      "indicate\n",
      "ins\n",
      "coverage\n",
      "providers\n",
      "special\n",
      "arojmo5zjc\n",
      "cimzia\n",
      "held\n",
      "pennington\n",
      "axial\n",
      "dangerous\n",
      "causing\n",
      "today's\n",
      "ways\n",
      "standalone\n",
      "stockmarketinsights\n",
      "injectable\n",
      "tcot\n",
      "leusm\n",
      "gone\n",
      "acne\n",
      "harvoni\n",
      "scared\n",
      "gonna\n",
      "natural\n",
      "relieve\n",
      "specific\n",
      "covered\n",
      "scripts\n",
      "named\n",
      "leading\n",
      "heat\n",
      "autoimmune\n",
      "symptom\n",
      "humira's\n",
      "crippling\n",
      "crack\n",
      "issue\n",
      "advertising\n",
      "contribution\n",
      "said\n",
      "equivalent\n",
      "transforming\n",
      "sandoz_global\n",
      "sharing\n",
      "mrc\n",
      "licenses\n",
      "antibody\n",
      "newsummit\n",
      "added\n",
      "ginger\n",
      "citrus\n",
      "oat\n",
      "cow\n",
      "milk\n",
      "soap\n",
      "inflamed\n",
      "antiseptic\n",
      "wjxlskup6h\n",
      "eliminating\n",
      "pathtozero\n",
      "leopharmaukie\n",
      "clear\n",
      "recipes\n",
      "born\n",
      "metriopharm\n",
      "iia\n",
      "gold\n",
      "bond\n",
      "diabetics\n",
      "bumpy\n",
      "neck\n",
      "chest\n",
      "dark\n",
      "spot\n",
      "min\n",
      "lotion\n",
      "investigation\n",
      "randomized\n",
      "coffee\n",
      "cellulite\n",
      "licensed\n",
      "tea\n",
      "soaps\n",
      "go2\n",
      "tvnxjy1tne\n",
      "hepatitisctrust\n",
      "htt\n",
      "online\n",
      "risks\n",
      "preclinical\n",
      "eliminate\n",
      "abbott\n",
      "cramer's\n",
      "lightning\n",
      "abt\n",
      "end\n",
      "demonstrate\n",
      "proposed\n",
      "reference\n",
      "lets\n",
      "connect\n",
      "helpful\n",
      "livelaughlove\n",
      "icer\n",
      "targeted\n",
      "epigenetic\n",
      "secrets\n",
      "critical\n",
      "illnesses\n",
      "chronicillness\n",
      "triggers\n",
      "'most\n",
      "eyeforpharma\n",
      "unitepharma\n",
      "seeking\n",
      "advisors\n",
      "countries\n",
      "prevent\n",
      "bacteria\n",
      "trigger\n",
      "move\n",
      "dovonex\n",
      "ointment\n",
      "skincare\n",
      "mechanism\n",
      "spinal\n",
      "upgraded\n",
      "aloe\n",
      "blind\n",
      "sp500\n",
      "doctor's\n",
      "customer\n",
      "migraine\n",
      "depression\n",
      "walk\n",
      "exercise\n",
      "cardiovascular\n",
      "metabolic\n",
      "pcsk9\n",
      "blockbuster\n",
      "japanese\n",
      "ministry\n",
      "labour\n",
      "welfare\n",
      "abbvies\n",
      "glecaprevir\n",
      "pibrentasvir\n",
      "grateful\n",
      "mhlw\n",
      "listen\n",
      "bill\n",
      "ongoing\n",
      "commitment\n",
      "bless\n",
      "weather\n",
      "dad\n",
      "stats\n",
      "berniesbookbank\n",
      "washington\n",
      "efpawards\n",
      "piper\n",
      "jaffray\n",
      "massive\n",
      "winner\n",
      "gun\n",
      "steers\n",
      "hopeful\n",
      "cso\n",
      "landmark\n",
      "manufacturing\n",
      "reiterates\n",
      "friends\n",
      "responsive\n",
      "webinar\n",
      "declarations\n",
      "supreme\n",
      "calls\n",
      "fourier\n",
      "sent\n",
      "rivals\n",
      "agree\n",
      "decided\n",
      "sensitive\n",
      "avoid\n",
      "mean\n",
      "colitis\n",
      "cancers\n",
      "amgenonco\n",
      "field\n",
      "central\n",
      "chicagojobs\n",
      "suit\n",
      "dexamethasone\n",
      "age\n",
      "sufferers\n",
      "tired\n",
      "tgr\n",
      "viraled_hep\n",
      "regarding\n",
      "joints\n",
      "inflammatory\n",
      "pills\n",
      "medicare\n",
      "copay\n",
      "ventricular\n",
      "arrhythmias\n",
      "sudden\n",
      "crazy\n",
      "talking\n",
      "playing\n",
      "easy\n",
      "whole\n",
      "fund\n",
      "genetic\n",
      "amp\n",
      "vitamin\n",
      "deficiency\n",
      "retweeted\n",
      "ahealthblog\n",
      "remedies\n",
      "individuals\n",
      "dating\n",
      "sleep\n",
      "disorders\n",
      "discovered\n",
      "ulcerative\n",
      "say\n",
      "sex\n",
      "transformation\n",
      "competitive\n",
      "speakerryan\n",
      "recommendations\n",
      "endlesstrax\n",
      "chief\n",
      "thepharmaletter\n",
      "rheumatologist\n",
      "pens\n",
      "commission\n",
      "presented\n",
      "stroke\n",
      "die\n",
      "rid\n",
      "reviews\n",
      "deciphering\n",
      "vol\n",
      "mild\n",
      "hours\n",
      "cosentyx\n",
      "joke\n",
      "enough\n",
      "hurts\n",
      "biggest\n",
      "japanążs\n",
      "thomas\n",
      "lynch\n",
      "parents\n",
      "safe\n",
      "abbviecanada\n",
      "medicines\n",
      "psoriaticarthritis\n",
      "spread\n",
      "aad17\n",
      "bmsfoundation\n",
      "underserved\n",
      "communities\n",
      "game\n",
      "specialty\n",
      "codes\n",
      "draft\n",
      "kids\n",
      "spend\n",
      "genetics\n",
      "unlike\n",
      "disabled\n",
      "medicaid\n",
      "fatty\n",
      "officer\n",
      "clonal\n",
      "evolution\n",
      "janssen\n",
      "guselkumab\n",
      "seller\n",
      "limited\n",
      "rheumnow\n",
      "becomes\n",
      "prior\n",
      "abbvieą\n",
      "outcome\n",
      "idea\n",
      "endometriosis\n",
      "healthywomen\n",
      "resistant\n",
      "unwanted\n",
      "unwonted\n",
      "esm\n",
      "stemecosystems\n",
      "trademark\n",
      "number\n",
      "problem\n",
      "adult\n",
      "sucks\n",
      "maintained\n",
      "kyowa\n",
      "kirin\n",
      "favor\n",
      "decreases\n",
      "onclive\n",
      "continues\n",
      "unusual\n",
      "importance\n",
      "pro\n",
      "fujifilm's\n",
      "prevails\n",
      "dosing\n",
      "pat\n",
      "fujif\n",
      "fujiy\n",
      "employees\n",
      "dedicated\n",
      "pace\n",
      "green\n",
      "resonate\n",
      "here's\n",
      "restructuring\n",
      "mrktstrategies\n",
      "tier\n",
      "franchises\n",
      "improved\n",
      "workers\n",
      "kyowakirin\n",
      "lady\n",
      "middle\n",
      "ppl\n",
      "government\n",
      "considering\n",
      "participating\n",
      "picture\n",
      "superior\n",
      "step\n",
      "toward\n",
      "somebody\n",
      "ame\n",
      "biospace\n",
      "janssenus\n",
      "petitions\n",
      "ipr\n",
      "abbvieäóťs\n",
      "ąž619\n",
      "p3wxssa7mz\n",
      "employeeappreciationday\n",
      "woundgod\n",
      "equityresearch\n",
      "mark\n",
      "shouldn't\n",
      "crohn\n",
      "derek\n",
      "fine\n",
      "irish\n",
      "genomes\n",
      "buyąą\n",
      "vicodin\n",
      "domain\n",
      "seized\n",
      "jaadjournals\n",
      "milestone\n",
      "yofie\n",
      "recognize\n",
      "large\n",
      "realworld\n",
      "difficult\n",
      "family\n",
      "reducing\n",
      "nicecomms\n",
      "excess\n",
      "website\n",
      "dentistry\n",
      "appears\n",
      "save\n",
      "mariatcardona\n",
      "thoughts\n",
      "spent\n",
      "protect\n",
      "extra\n",
      "average\n",
      "raised\n",
      "creating\n",
      "young\n",
      "strategies\n",
      "systematic\n",
      "cold\n",
      "hot\n",
      "differ\n",
      "cme\n",
      "medpage\n",
      "coconut\n",
      "glance\n",
      "playlist\n",
      "african\n",
      "imfmyeloma\n",
      "there's\n",
      "philosophy\n",
      "flu\n",
      "phones\n",
      "philippines\n",
      "spoonies\n",
      "returned\n",
      "illness\n",
      "self\n",
      "wang\n",
      "indications\n",
      "division\n",
      "teens\n",
      "coincidence\n",
      "outside\n",
      "leaders\n",
      "google\n",
      "san\n",
      "francisco\n",
      "grand\n",
      "west\n",
      "discovery\n",
      "advocacy\n",
      "recommending\n",
      "differences\n",
      "talks\n",
      "dementia\n",
      "hidradenitissuppurativa\n",
      "attend\n",
      "teen\n",
      "matthewherper\n",
      "although\n",
      "pharmacokinetics\n",
      "spotlight\n",
      "immunogenicity\n",
      "mhra\n",
      "epivax\n",
      "necessary\n",
      "nationalankylosingspondylitissociety\n",
      "survey\n",
      "session\n",
      "exchange\n",
      "healthcentral\n",
      "acrheum\n",
      "shock\n",
      "featuring\n",
      "phrma\n",
      "astellasus\n",
      "profile\n",
      "spine\n",
      "zurich\n",
      "swelling\n",
      "missing\n",
      "abbvie_de\n",
      "license\n",
      "bigpharma\n",
      "inside\n",
      "webmd\n",
      "epidemiology\n",
      "landscape\n",
      "remain\n",
      "challenges\n",
      "glpg\n",
      "initiates\n",
      "glpg3067\n",
      "payment\n",
      "forecast\n",
      "rituximab\n",
      "improves\n",
      "galapagos\n",
      "disorder\n",
      "rayavenfdo\n",
      "mandatory\n",
      "falling\n",
      "dented\n",
      "created\n",
      "manufacturer\n",
      "societe\n",
      "generale\n",
      "omg\n",
      "marketed\n",
      "npf\n",
      "conducting\n",
      "approaches\n",
      "complications\n",
      "joseph\n",
      "mine\n",
      "reduction\n",
      "repair\n",
      "julianne\n",
      "hough\n",
      "juliannehough\n",
      "estimated\n",
      "trump\n",
      "mum\n",
      "rheumatologists\n",
      "worry\n",
      "husband\n",
      "personal\n",
      "versions\n",
      "rheumatic\n",
      "dental\n",
      "insight\n",
      "one\n",
      "communications\n",
      "flares\n",
      "certain\n",
      "amgevitaä\n",
      "amgenäóťs\n",
      "ok'd\n",
      "etc\n",
      "maintenance\n",
      "tool\n",
      "herbal\n",
      "healing\n",
      "prognosis\n",
      "gluten\n",
      "themightysite\n",
      "predicted\n",
      "disappear\n",
      "sjzy9xfbeo\n",
      "amgevita\n",
      "webcast\n",
      "vegan\n",
      "rheumjc\n",
      "fibromyalgia\n",
      "osteoarthritis\n",
      "fracture\n",
      "pubmed\n",
      "ncbi\n",
      "standard\n",
      "guide\n",
      "ideas\n",
      "gum\n",
      "essential\n",
      "oils\n",
      "gout\n",
      "gain\n",
      "predicting\n",
      "momsvictories\n",
      "pages\n",
      "function\n",
      "destroying\n",
      "wheat\n",
      "cushions\n",
      "printable\n",
      "sector\n",
      "hashimoto\n",
      "morry\n",
      "smulevitz\n",
      "ambassadors\n",
      "wife\n",
      "hemp\n",
      "modifying\n",
      "nausea\n",
      "handling\n",
      "healed\n",
      "heartbreak\n",
      "finger\n",
      "b_crawford\n",
      "affects\n",
      "medivizor\n",
      "biomarker\n",
      "'could\n",
      "prediction\n",
      "rawarrior\n",
      "teams\n",
      "volunteers\n",
      "collagen\n",
      "connection\n",
      "characterized\n",
      "teeth\n",
      "brave\n",
      "vitamins\n",
      "everydayhealth\n",
      "organic\n",
      "teas\n",
      "fingers\n",
      "earlier\n",
      "heals\n",
      "nutrition\n",
      "macular\n",
      "degeneration\n",
      "vertigo\n",
      "frustrated\n",
      "onset\n",
      "near\n",
      "books\n",
      "guideline\n",
      "systemic\n",
      "rheumaarthritis\n",
      "goal\n",
      "water\n",
      "pfizer's\n",
      "gotten\n",
      "humiraäó_\n",
      "dealing\n",
      "stiffness\n",
      "space\n",
      "stiff\n",
      "ease\n",
      "eat\n",
      "aids\n",
      "nonischemic\n",
      "cream\n",
      "rheumatoid_arthritis\n",
      "biological\n",
      "glutenfree\n",
      "tracker\n",
      "newstalkfm\n",
      "suffers\n",
      "sjogren's\n",
      "tracinnasv\n",
      "dividends\n",
      "emotional\n",
      "lab\n",
      "celiac\n",
      "rpt\n",
      "compares\n",
      "medicalaffairs\n",
      "sqmbvarsf0\n",
      "kindle\n",
      "cookbook\n",
      "bones\n",
      "muscles\n",
      "jointpain\n",
      "citrullinated\n",
      "yoga\n",
      "caitlin\n",
      "samson\n",
      "arthritis'\n",
      "arthritic\n",
      "variety\n",
      "hair\n",
      "qmqxxluv4g\n",
      "authorisation\n",
      "allow\n",
      "secures\n",
      "xeljanzž\n",
      "citrate\n",
      "union\n",
      "golimumab\n",
      "chances\n",
      "fibro\n",
      "dry\n",
      "drive\n",
      "institute\n",
      "miracle\n",
      "committed\n",
      "attack\n",
      "warrior\n",
      "relations\n",
      "occupational\n",
      "c0dgytaqdd\n",
      "cocktail\n",
      "daily_express\n",
      "unique\n",
      "m2gen\n",
      "orien\n",
      "avatarą\n",
      "avatar\n",
      "result\n",
      "bees\n",
      "extract\n",
      "ultrasound\n",
      "contact\n",
      "example\n",
      "wild\n",
      "remedy\n",
      "died\n",
      "shingles\n",
      "supplies\n",
      "rickitt\n",
      "front\n",
      "topical\n",
      "attacking\n",
      "roots\n",
      "rct\n",
      "c0nvey\n",
      "itch\n",
      "volunteer\n",
      "enters\n",
      "oatmeal\n",
      "hfaac4gctz\n",
      "indigenous\n",
      "blackseed\n",
      "rosehips\n",
      "c4pkoqsnbn\n",
      "homeopathic\n",
      "homeopathy\n",
      "hematologic\n",
      "manufacturers\n",
      "assistance\n",
      "psoriasiscauses\n",
      "řüß\n",
      "patches\n",
      "lesions\n",
      "rosemary\n",
      "antioxidants\n",
      "rosacea\n",
      "redness\n",
      "dermacura\n",
      "rejuvaderm\n",
      "dryness\n",
      "lavender\n",
      "shea\n",
      "butter\n",
      "tm9qgyagru\n",
      "katie\n",
      "lowes\n",
      "psoriasisuk\n",
      "crete\n",
      "abrasion\n",
      "flaky\n",
      "kmqlqdjolq\n",
      "winter\n",
      "rescue\n",
      "katieqlowes\n",
      "honey\n",
      "appearance\n",
      "gel\n",
      "pure\n",
      "psoriasisinsidestory\n",
      "lines\n",
      "transfer\n",
      "mother's\n",
      "plasma\n",
      "supplemental\n",
      "targets\n",
      "accepts\n",
      "label\n",
      "ingredient\n",
      "vice\n",
      "applied\n",
      "aadmember\n",
      "sbla\n",
      "decrease\n",
      "m5xycmmq9h\n",
      "gaga\n",
      "avillion\n",
      "merckgroup\n",
      "nanobody\n",
      "coconutoil\n",
      "kgaa's\n",
      "fingernail\n",
      "humiraž\n",
      "prescribing\n",
      "pharmacies\n",
      "proposal\n",
      "abbvie'säó_\n",
      "inclusion\n",
      "getyourskinout\n",
      "healioderm\n",
      "treats\n",
      "outsources\n",
      "classes\n",
      "cyu8kb0tsl\n",
      "ladygaga\n",
      "tljjpcbv7q\n",
      "ink\n",
      "stops\n",
      "chatbot\n",
      "chatbothcv\n",
      "msdsalutebot\n",
      "lamberto\n",
      "andreotti\n",
      "leverage\n",
      "australia\n",
      "reta\n",
      "addactionuk\n",
      "metropolitan\n",
      "aacr\n",
      "dtc\n",
      "hcmktg\n",
      "nielsen\n",
      "xpuhy1toql\n",
      "womeninstem\n",
      "reata\n",
      "yearly\n",
      "defense\n",
      "epicast\n",
      "attacked\n",
      "jkj193741\n",
      "openborders\n",
      "raped\n",
      "merkel\n",
      "migrant\n",
      "bests\n",
      "muster\n",
      "emerge\n",
      "shadows\n",
      "reportingtexas\n",
      "van\n",
      "plenary\n",
      "appreciative\n",
      "they're\n",
      "steady\n",
      "arconic\n",
      "avon\n",
      "bioepis\n",
      "favourable\n",
      "ruling\n",
      "pulse\n",
      "mikegoodma\n",
      "tgtxdough\n",
      "maxjacobsedison\n",
      "u2hcqhmwet\n",
      "andybiotech\n",
      "biosims\n",
      "defence\n",
      "league\n",
      "'country\n",
      "mile'\n",
      "biopharmareport\n",
      "jonathanrockoff\n",
      "overturns\n",
      "plcg2\n"
     ]
    }
   ],
   "source": [
    "for i in dictionary:\n",
    "    print(dictionary[i])\n",
    "print(dictionary[2])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
